
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Unraveling tumor cell-tumor microenvironment crosstalk through antibody array technologies (Review) - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251CC08AEEFC93051CC000627C4E86.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="intjoncol">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370358/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="International Journal of Oncology">
<meta name="citation_title" content="Unraveling tumor cell-tumor microenvironment crosstalk through antibody array technologies (Review)">
<meta name="citation_author" content="Yanlin Wang">
<meta name="citation_author_institution" content="Raybiotech Co., Ltd., Guangzhou, Guangdong 510600, P.R. China">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, P.R. China">
<meta name="citation_author_institution" content="South China Biochip Research Center, Guangzhou, Guangdong 510600, P.R. China">
<meta name="citation_author" content="Shuhong Luo">
<meta name="citation_author_institution" content="Raybiotech Co., Ltd., Guangzhou, Guangdong 510600, P.R. China">
<meta name="citation_author_institution" content="South China Biochip Research Center, Guangzhou, Guangdong 510600, P.R. China">
<meta name="citation_author_institution" content="RayBiotech Inc., Peachtree Corners, GA 30092, USA">
<meta name="citation_author" content="Hua Dong">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, P.R. China">
<meta name="citation_author_institution" content="National Engineering Research Center for Tissue Restoration and Reconstruction (NERC-TRR), Guangzhou, Guangdong 510006, P.R. China">
<meta name="citation_author" content="Ruo-Pan Huang">
<meta name="citation_author_institution" content="Raybiotech Co., Ltd., Guangzhou, Guangdong 510600, P.R. China">
<meta name="citation_author_institution" content="South China Biochip Research Center, Guangzhou, Guangdong 510600, P.R. China">
<meta name="citation_author_institution" content="RayBiotech Inc., Peachtree Corners, GA 30092, USA">
<meta name="citation_author_institution" content="Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="67">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="81">
<meta name="citation_doi" content="10.3892/ijo.2025.5787">
<meta name="citation_pmid" content="40849816">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370358/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370358/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370358/pdf/ijo-67-04-05787.pdf">
<meta name="description" content="The tumor microenvironment (TME) consists of tumor cells, stromal cells, infiltrating immune cells and non-cellular components such as extracellular matrix, blood vessels and a wide variety of secreted proteins. Evidence shows that beyond supporting ...">
<meta name="og:title" content="Unraveling tumor cell-tumor microenvironment crosstalk through antibody array technologies (Review)">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The tumor microenvironment (TME) consists of tumor cells, stromal cells, infiltrating immune cells and non-cellular components such as extracellular matrix, blood vessels and a wide variety of secreted proteins. Evidence shows that beyond supporting ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370358/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370358">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3892/ijo.2025.5787"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ijo-67-04-05787.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370358%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370358/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370358/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370358/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-intjoncol.gif" alt="International Journal of Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to International Journal of Oncology" title="Link to International Journal of Oncology" shape="default" href="http://www.spandidos-publications.com/ijo" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Int J Oncol</button></div>. 2025 Aug 18;67(4):81. doi: <a href="https://doi.org/10.3892/ijo.2025.5787" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3892/ijo.2025.5787</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Int%20J%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Int%20J%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int%20J%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Int%20J%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Unraveling tumor cell-tumor microenvironment crosstalk through antibody array technologies (Review)</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yanlin Wang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yanlin Wang</span></h3>
<div class="p">
<sup>1</sup>Raybiotech Co., Ltd., Guangzhou, Guangdong 510600, P.R. China</div>
<div class="p">
<sup>2</sup>Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, P.R. China</div>
<div class="p">
<sup>3</sup>South China Biochip Research Center, Guangzhou, Guangdong 510600, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yanlin Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Shuhong Luo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Shuhong Luo</span></h3>
<div class="p">
<sup>1</sup>Raybiotech Co., Ltd., Guangzhou, Guangdong 510600, P.R. China</div>
<div class="p">
<sup>3</sup>South China Biochip Research Center, Guangzhou, Guangdong 510600, P.R. China</div>
<div class="p">
<sup>4</sup>RayBiotech Inc., Peachtree Corners, GA 30092, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuhong Luo</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dong%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Hua Dong</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Hua Dong</span></h3>
<div class="p">
<sup>2</sup>Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, P.R. China</div>
<div class="p">
<sup>5</sup>National Engineering Research Center for Tissue Restoration and Reconstruction (NERC-TRR), Guangzhou, Guangdong 510006, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dong%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hua Dong</span></a>
</div>
</div>
<sup>2,</sup><sup>5,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20RP%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ruo-Pan Huang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ruo-Pan Huang</span></h3>
<div class="p">
<sup>1</sup>Raybiotech Co., Ltd., Guangzhou, Guangdong 510600, P.R. China</div>
<div class="p">
<sup>3</sup>South China Biochip Research Center, Guangzhou, Guangdong 510600, P.R. China</div>
<div class="p">
<sup>4</sup>RayBiotech Inc., Peachtree Corners, GA 30092, USA</div>
<div class="p">
<sup>6</sup>Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20RP%22%5BAuthor%5D" class="usa-link"><span class="name western">Ruo-Pan Huang</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4,</sup><sup>6,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-ijo-67-04-05787">
<sup>1</sup>Raybiotech Co., Ltd., Guangzhou, Guangdong 510600, P.R. China</div>
<div id="af2-ijo-67-04-05787">
<sup>2</sup>Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, P.R. China</div>
<div id="af3-ijo-67-04-05787">
<sup>3</sup>South China Biochip Research Center, Guangzhou, Guangdong 510600, P.R. China</div>
<div id="af4-ijo-67-04-05787">
<sup>4</sup>RayBiotech Inc., Peachtree Corners, GA 30092, USA</div>
<div id="af5-ijo-67-04-05787">
<sup>5</sup>National Engineering Research Center for Tissue Restoration and Reconstruction (NERC-TRR), Guangzhou, Guangdong 510006, P.R. China</div>
<div id="af6-ijo-67-04-05787">
<sup>6</sup>Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China</div>
<div class="author-notes p">
<div class="fn" id="c1-ijo-67-04-05787">
<sup>✉</sup><p class="display-inline">Correspondence to: Dr Ruo-Pan Huang, RayBiotech Inc., Peachtree Corners, 3607 Parkway Lane, GA 30092, USA, E-mail: <span>rhuang@raybiotech.com</span></p>
</div>
<div class="fn" id="c2-ijo-67-04-05787">
<sup>✉</sup><p class="display-inline">Professor Hua Dong, Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, 381 Wushan Road, Tianhe, Guangzhou, Guangdong 510641, P.R. China, E-mail: <span>donghua@scut.edu.cn</span></p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 21; Accepted 2025 Jul 22; Collection date 2025 Oct.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright: © 2025 Wang et al.</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-NonCommercial-NoDerivs License</a>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370358  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40849816/" class="usa-link">40849816</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The tumor microenvironment (TME) consists of tumor cells, stromal cells, infiltrating immune cells and non-cellular components such as extracellular matrix, blood vessels and a wide variety of secreted proteins. Evidence shows that beyond supporting tumor growth, the TME also promotes tumor cell proliferation and invasion and contributes to treatment resistance, ultimately affecting patient prognosis. Cell-to-cell communication within the TME is driven by secreted proteins such as cytokines, chemokines, growth factors and interferons, which are produced not only by tumor cells but also by various stromal cells and immune cells. These proteins form a complex signaling network that promotes tumor cell proliferation and invasion and enables tumors to evade innate and adaptive immune responses. Antibody arrays are a technology that can simultaneously screen hundreds of secreted proteins in complex biological samples, aiding in the exploration of this complex signaling network. By combining high-throughput multiplex immunoassays such as antibody arrays with cellular and molecular biology techniques, researchers have uncovered complex regulatory mechanisms of cytokine networks within the TME. The present review summarized recent findings on the communication between tumor cells and the TME, as well as key secreted proteins essential for tumor progression and the development of therapeutic resistance. In addition, it discusses how high-throughput antibody arrays contribute to our understanding of regulatory networks of secreted proteins in the TME.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Key words:</strong> antibody array, biomarker, cytokine, crosstalk, secretome, signaling pathway, tumor cell, tumor microenvironment</p></section></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>The understanding of cancer pathogenesis and therapeutic strategies has shifted from a cancer cell-centric model to recognizing the critical role of the tumor microenvironment (TME). In the early days, tumor research primarily focused on the tumor cells themselves, aiming to elucidate how genetic mutations and alterations in signaling pathways contributed to tumor progression and poor clinical prognosis (<a href="#b1-ijo-67-04-05787" class="usa-link" aria-describedby="b1-ijo-67-04-05787">1</a>). Recent studies have revealed that the TME plays a pivotal role in tumorigenesis, progression and therapeutic resistance (<a href="#b2-ijo-67-04-05787" class="usa-link" aria-describedby="b2-ijo-67-04-05787">2</a>,<a href="#b3-ijo-67-04-05787" class="usa-link" aria-describedby="b3-ijo-67-04-05787">3</a>). The TME constitutes a dynamic ecosystem co-evolving with malignant cells and host components, comprising both cellular and non-cellular elements. Cellular components mainly include stromal cells (fibroblasts, endothelial cells and pericytes) and immune cells [T cells, macrophages and natural killer (NK) cells]. Non-cellular components include inflammatory cytokines, growth factors, chemokines, metabolites and the extracellular matrix (ECM) (<a href="#b2-ijo-67-04-05787" class="usa-link" aria-describedby="b2-ijo-67-04-05787">2</a>). ECM remodeling mediated by stromal cells and matrix metalloproteinases (MMPs) provides essential structural support for tumor invasion and metastasis. On the other hand, immune cells exhibit dual regulatory roles; while capable of tumoricidal activity through cytotoxic mechanisms, they may also adopt tumor-promoting phenotypes that create an immunosuppressive microenvironment (<a href="#b4-ijo-67-04-05787" class="usa-link" aria-describedby="b4-ijo-67-04-05787">4</a>). The hallmarks of cancer include sustaining proliferative signaling, inducing angiogenesis, resisting cell death, triggering tumor cell invasion and metastasis, activating tumor-promoting inflammation and evading immune surveillance. Acquisition and maintenance of these features depend not only on cancer cells but also on dynamic interactions with the TME (<a href="#b5-ijo-67-04-05787" class="usa-link" aria-describedby="b5-ijo-67-04-05787">5</a>). The interplay between tumor cells and the TME greatly affects tumor progression and clinical outcomes. These inter-cellular communications are driven by multiple coordinated pathways and complex protein networks, including cytokines, chemokines, growth factors and matrix-degrading enzymes, which collectively promote tumor cell proliferation, invasion and survival (<a href="#b3-ijo-67-04-05787" class="usa-link" aria-describedby="b3-ijo-67-04-05787">3</a>). Accurately identifying these dynamic interactions has represented a critical challenge in oncological research.</p>
<p>Antibody arrays, as one of the major affinity-based platforms, enable the parallel detection of hundreds to thousands of proteins. This powerful technology can uncover expression patterns of key factors across individual or multiple cell populations. Particularly suited for exploring overall secreted profiles in tumor tissues, it effectively analyzes protein expression signatures across different models (<a href="#b6-ijo-67-04-05787" class="usa-link" aria-describedby="b6-ijo-67-04-05787">6</a>). By mapping these dynamic molecular signals, antibody arrays reveal complex communication networks among diverse cellular components within tumor microenvironments, offering new insights into cell-to-cell interactions and coordinated regulatory mechanisms. The present review focused on current findings on tumor-TME crosstalk, identifying key secreted factors that promote malignancy and therapy resistance across different tumor types and demonstrating how high-throughput antibody arrays enable systematic profiling of TME signaling pathways.</p></section><section id="sec2"><h2 class="pmc_sec_title">2. Components and communication networks in TME</h2>
<section id="sec3"><h3 class="pmc_sec_title">Cellular components of the TME</h3>
<p>The term TME specifically refers to the microenvironment of solid tumors, which comprises not only malignant cells but also a large population of immune and stromal cells, along with non-cellular components (<a href="#f1-ijo-67-04-05787" class="usa-link">Fig. 1</a>). The main cellular components include fibroblasts, endothelial cells, adipocytes, innate immune cells and adaptive immune cells. These cells collectively modulate the local TME through dynamic interactions, exhibiting dual roles that either promote or antagonize tumor progression.</p>
<figure class="fig xbox font-sm" id="f1-ijo-67-04-05787"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370358_ijo-67-04-05787-g00.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/357b/12370358/de3882ecd93d/ijo-67-04-05787-g00.jpg" loading="lazy" height="576" width="677" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1-ijo-67-04-05787/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overview of the (TME) structure. The complex TME is composed of various cellular and non-cellular components. Tumor cells, stromal cells, and immune cells interact through direct contact or secreted factors, collectively influencing tumor progression. TME, tumor microenvironment; CAF, cancer-associated fibroblast; DC, dendritic cell; ECM, extracellular matrix; NK cell, natural killer cell; Treg, regulatory T cell.</p></figcaption></figure><p>Cancer-associated fibroblasts (CAFs), the most abundant stromal cell population within the TME, play pivotal roles in cancer progression. Their identified functions include ECM remodeling to facilitate tumor invasion (<a href="#b7-ijo-67-04-05787" class="usa-link" aria-describedby="b7-ijo-67-04-05787">7</a>), promotion of cancer cell stemness (<a href="#b8-ijo-67-04-05787" class="usa-link" aria-describedby="b8-ijo-67-04-05787">8</a>), enhancement of chemoresistance to targeted therapies (<a href="#b9-ijo-67-04-05787" class="usa-link" aria-describedby="b9-ijo-67-04-05787">9</a>) and reprogramming of the immune environment within tumors (<a href="#b10-ijo-67-04-05787" class="usa-link" aria-describedby="b10-ijo-67-04-05787">10</a>,<a href="#b11-ijo-67-04-05787" class="usa-link" aria-describedby="b11-ijo-67-04-05787">11</a>). Studies have revealed that CAFs constitute a heterogeneous population originating from diverse precursor cells through either local differentiation or recruitment to tumor sites (<a href="#b2-ijo-67-04-05787" class="usa-link" aria-describedby="b2-ijo-67-04-05787">2</a>,<a href="#b12-ijo-67-04-05787" class="usa-link" aria-describedby="b12-ijo-67-04-05787">12</a>,<a href="#b13-ijo-67-04-05787" class="usa-link" aria-describedby="b13-ijo-67-04-05787">13</a>). While activation of local tissue-resident fibroblasts and stellate cells is recognized as the primary source of CAFs (<a href="#b12-ijo-67-04-05787" class="usa-link" aria-describedby="b12-ijo-67-04-05787">12</a>), alternative origins include adipocytes, bone marrow-derived mesenchymal stem cells, epithelial cells undergoing epithelial-mesenchymal transition (EMT) and endothelial cells undergoing endothelial-mesenchymal transition (<a href="#b13-ijo-67-04-05787" class="usa-link" aria-describedby="b13-ijo-67-04-05787">13</a>,<a href="#b14-ijo-67-04-05787" class="usa-link" aria-describedby="b14-ijo-67-04-05787">14</a>). In malignant tumors, neoplastic cells drive the transformation of normal fibroblasts into CAFs by activating inflammatory pathways through secretion of cytokines, growth factors and functional DNAs or non-coding RNAs (<a href="#b15-ijo-67-04-05787" class="usa-link" aria-describedby="b15-ijo-67-04-05787">15</a>,<a href="#b16-ijo-67-04-05787" class="usa-link" aria-describedby="b16-ijo-67-04-05787">16</a>). Furthermore, other non-malignant cells in the TME can induce CAF conversion, as evidenced by findings showing that M2-polarized macrophages promote the transformation of intra-tumoral normal fibroblasts into CAFs via paracrine signaling pathways (<a href="#b17-ijo-67-04-05787" class="usa-link" aria-describedby="b17-ijo-67-04-05787">17</a>). The heterogeneity of CAFs markedly influences subsequent tumor progression. Studies have identified specific CAF subtypes associated with characteristics such as tumorigenesis, chemotherapy resistance and immunosuppression (<a href="#b11-ijo-67-04-05787" class="usa-link" aria-describedby="b11-ijo-67-04-05787">11</a>,<a href="#b18-ijo-67-04-05787" class="usa-link" aria-describedby="b18-ijo-67-04-05787">18</a>,<a href="#b19-ijo-67-04-05787" class="usa-link" aria-describedby="b19-ijo-67-04-05787">19</a>). However, the extent of CAF heterogeneity and the potential tumor-modulating effects exerted by distinct CAF subtypes remain under investigation.</p>
<p>Tumor-associated macrophages (TAMs) constitute nearly half of the cellular components within solid tumors, playing pivotal roles in tumor progression (<a href="#b20-ijo-67-04-05787" class="usa-link" aria-describedby="b20-ijo-67-04-05787">20</a>). These cells, which are derived from peripheral blood mononuclear cells, differentiate into macrophages when stimulated by various factors secreted by tumor and stromal cells, such as chemokines, cytokines and growth factors (<a href="#b21-ijo-67-04-05787" class="usa-link" aria-describedby="b21-ijo-67-04-05787">21</a>). Within the TME, TAMs are markedly involved in tumor proliferation, invasion, metastasis and angiogenesis, with TAM-derived cytokines acting as key regulators in these processes (<a href="#b22-ijo-67-04-05787" class="usa-link" aria-describedby="b22-ijo-67-04-05787">22</a>,<a href="#b23-ijo-67-04-05787" class="usa-link" aria-describedby="b23-ijo-67-04-05787">23</a>). TAMs are traditionally classified into M1 and M2 subtypes, with M1-like macrophages involved in pathogen clearance, inflammatory response and anti-tumor immune functions (<a href="#b24-ijo-67-04-05787" class="usa-link" aria-describedby="b24-ijo-67-04-05787">24</a>), while M2-polarized macrophages exhibit anti-inflammatory properties and promote tumor cell proliferation, metastasis and immune evasion (<a href="#b25-ijo-67-04-05787" class="usa-link" aria-describedby="b25-ijo-67-04-05787">25</a>,<a href="#b26-ijo-67-04-05787" class="usa-link" aria-describedby="b26-ijo-67-04-05787">26</a>). Recent evidence suggests that TAM phenotypic diversity <em>in vivo</em> exceeds this binary classification due to tumor heterogeneity (<a href="#b27-ijo-67-04-05787" class="usa-link" aria-describedby="b27-ijo-67-04-05787">27</a>). As a highly diverse immune cell population with various phenotypes and functions, TAMs undergo differentiation influenced by multiple factors, leading to heterogeneous pro-tumorigenic capabilities. For instance, Wang <em>et al</em> (<a href="#b28-ijo-67-04-05787" class="usa-link" aria-describedby="b28-ijo-67-04-05787">28</a>) demonstrated that hepatocellular carcinoma-derived C-C motif chemokine ligand 2 (CCL2) and CCL5 attract TAMs and induce their polarization towards pro-tumorigenic M2-like macrophages. Similarly, Su <em>et al</em> (<a href="#b29-ijo-67-04-05787" class="usa-link" aria-describedby="b29-ijo-67-04-05787">29</a>) found that breast cancer cells activate macrophages to a TAM-like phenotype by secreting granulocyte-macrophage colony-stimulating factor (GM-CSF). In prostate cancer, CAFs recruit and activate monocytes through C-X-C motif chemokine ligand 12 (CXCL12) and CXCL14 chemokines to generate M2-polarized macrophages (<a href="#b30-ijo-67-04-05787" class="usa-link" aria-describedby="b30-ijo-67-04-05787">30</a>,<a href="#b31-ijo-67-04-05787" class="usa-link" aria-describedby="b31-ijo-67-04-05787">31</a>). This heterogeneity leads to complex regulatory interactions between TAMs and tumor tissues.</p>
<p>As well as macrophages, other immune cells also play critical roles in tumor progression or anti-tumor surveillance. Cancer patients exhibit diminished immune surveillance capacity and immune dysregulation, including imbalances in CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells and associated cytokines (<a href="#b32-ijo-67-04-05787" class="usa-link" aria-describedby="b32-ijo-67-04-05787">32</a>,<a href="#b33-ijo-67-04-05787" class="usa-link" aria-describedby="b33-ijo-67-04-05787">33</a>). Thymus-derived naive CD4<sup>+</sup> T cells differentiate into distinct subsets upon antigenic stimulation in the periphery: T-helper 1 cells (Th1) are characterized by secretion of interferon-γ (IFN-γ), while Th2 is defined by interleukin-4 (IL-4) production (<a href="#b34-ijo-67-04-05787" class="usa-link" aria-describedby="b34-ijo-67-04-05787">34</a>). Another subset comprises regulatory T cells (Tregs), which play a pivotal role in attenuating anti-tumor immune responses (<a href="#b35-ijo-67-04-05787" class="usa-link" aria-describedby="b35-ijo-67-04-05787">35</a>). Tregs express the transcription factor Foxp3 and surface markers CD25/CD127, suppressing the function of effector T cells and antigen-presenting cells through direct cell-cell contact and secretion of inhibitory cytokines like transforming growth factor-β (TGF-β) and IL-10 (<a href="#b35-ijo-67-04-05787" class="usa-link" aria-describedby="b35-ijo-67-04-05787">35</a>,<a href="#b36-ijo-67-04-05787" class="usa-link" aria-describedby="b36-ijo-67-04-05787">36</a>). Myeloid-derived suppressor cells (MDSCs), originating from aberrant myeloid differentiation of hematopoietic stem cells, exhibit immunosuppressive properties (<a href="#b37-ijo-67-04-05787" class="usa-link" aria-describedby="b37-ijo-67-04-05787">37</a>,<a href="#b38-ijo-67-04-05787" class="usa-link" aria-describedby="b38-ijo-67-04-05787">38</a>). Accumulating evidence highlights MDSCs as central components of the malignant TME, critically driving tumor progression and chemoresistance through secretion of inflammatory factors and chemokines such as IL-6 and CXCL family members (<a href="#b39-ijo-67-04-05787" class="usa-link" aria-describedby="b39-ijo-67-04-05787">39</a>,<a href="#b40-ijo-67-04-05787" class="usa-link" aria-describedby="b40-ijo-67-04-05787">40</a>). Neutrophils, the most abundant leukocytes in human blood, represent a significant proportion of the TME in multiple malignancies (<a href="#b41-ijo-67-04-05787" class="usa-link" aria-describedby="b41-ijo-67-04-05787">41</a>,<a href="#b42-ijo-67-04-05787" class="usa-link" aria-describedby="b42-ijo-67-04-05787">42</a>). These cells demonstrate functional plasticity and are recruited to tumor tissues via specific cytokines and chemokines during solid tumor progression, where they adopt context-dependent roles (<a href="#b42-ijo-67-04-05787" class="usa-link" aria-describedby="b42-ijo-67-04-05787">42</a>,<a href="#b43-ijo-67-04-05787" class="usa-link" aria-describedby="b43-ijo-67-04-05787">43</a>). Neutrophils can be classified into anti-tumor N1 and pro-tumor N2 subtypes (<a href="#b44-ijo-67-04-05787" class="usa-link" aria-describedby="b44-ijo-67-04-05787">44</a>). A subset of neutrophils may exert anti-cancer effects through reactive oxygen species (ROS) and neutrophil elastase release (<a href="#b45-ijo-67-04-05787" class="usa-link" aria-describedby="b45-ijo-67-04-05787">45</a>,<a href="#b46-ijo-67-04-05787" class="usa-link" aria-describedby="b46-ijo-67-04-05787">46</a>); however, the majority are polarized into pro-tumorigenic phenotypes by factors within the TME (<a href="#b47-ijo-67-04-05787" class="usa-link" aria-describedby="b47-ijo-67-04-05787">47</a>). N2 neutrophils promote tumor cell proliferation, angiogenesis and metastasis via secretion of pro-tumorigenic molecules, while also fostering an immunosuppressive TME through interactions with macrophages, NK cells and T cells (<a href="#b43-ijo-67-04-05787" class="usa-link" aria-describedby="b43-ijo-67-04-05787">43</a>,<a href="#b48-ijo-67-04-05787" class="usa-link" aria-describedby="b48-ijo-67-04-05787">48</a>,<a href="#b49-ijo-67-04-05787" class="usa-link" aria-describedby="b49-ijo-67-04-05787">49</a>).</p></section><section id="sec4"><h3 class="pmc_sec_title">Signal transduction mediated by cytokines</h3>
<p>Cytokines are a class of secreted proteins that mediate intercellular communication. Broadly defined, cytokines encompass a diverse group of secreted molecules including chemokines, growth factors, angiogenic factors, soluble receptors and extracellular proteases (<a href="#b50-ijo-67-04-05787" class="usa-link" aria-describedby="b50-ijo-67-04-05787">50</a>). These proteins not only exhibit cancer-suppressive functions but also participate in regulating physiological processes closely associated with tumor initiation, progression and metastasis, such as inflammation, apoptosis, migration and angiogenesis (<a href="#b2-ijo-67-04-05787" class="usa-link" aria-describedby="b2-ijo-67-04-05787">2</a>,<a href="#b4-ijo-67-04-05787" class="usa-link" aria-describedby="b4-ijo-67-04-05787">4</a>).</p>
<p>Multiple factors directly regulate tumor progression by modulating tumor cell proliferation and intra-tumoral vascular formation. For instance, vascular endothelial growth factors (VEGF) and its downstream signaling pathways are overexpressed in most malignancies, demonstrating dual functions in promoting angiogenesis and enhancing vascular permeability through specific induction of endothelial cell division, proliferation and migration (<a href="#b51-ijo-67-04-05787" class="usa-link" aria-describedby="b51-ijo-67-04-05787">51</a>,<a href="#b52-ijo-67-04-05787" class="usa-link" aria-describedby="b52-ijo-67-04-05787">52</a>). Similarly, insulin-like growth factor-1 (IGF-1) binds to its receptor IGF-1R to activate PI3K/AKT and MEK/ERK signaling pathways, thereby regulating tumor cell proliferation, invasion and metastasis (<a href="#b53-ijo-67-04-05787" class="usa-link" aria-describedby="b53-ijo-67-04-05787">53</a>). Notably, IGF-1R has been found widely expressed across various cell types in the TME, including epithelial cancer cells, CAFs and myeloid cells (<a href="#b54-ijo-67-04-05787" class="usa-link" aria-describedby="b54-ijo-67-04-05787">54</a>). TGF-β, a pleiotropic growth factor, exhibits dual functionality by suppressing tumor cell growth while promoting cancer progression through EMT induction under specific conditions, conferring stem-like properties to cancer cells (<a href="#b55-ijo-67-04-05787" class="usa-link" aria-describedby="b55-ijo-67-04-05787">55</a>). Additionally, aberrant expression of factors such as fibroblast growth factor (FGF), epidermal growth factor (EGF) and hepatocyte growth factor (HGF) markedly promotes tumor and stromal cell proliferation along with angiogenesis (<a href="#b56-ijo-67-04-05787" class="usa-link" aria-describedby="b56-ijo-67-04-05787">56</a>,<a href="#b57-ijo-67-04-05787" class="usa-link" aria-describedby="b57-ijo-67-04-05787">57</a>).</p>
<p>Furthermore, cellular components within the TME secrete inflammatory cytokines and chemokines that exert complex effects through autocrine and paracrine mechanisms. IL-6 demonstrates pleiotropic pro-inflammatory functions, promoting B and T cell differentiation while directly stimulating tumor cell proliferation and chemoresistance (<a href="#b58-ijo-67-04-05787" class="usa-link" aria-describedby="b58-ijo-67-04-05787">58</a>,<a href="#b59-ijo-67-04-05787" class="usa-link" aria-describedby="b59-ijo-67-04-05787">59</a>). The pro-inflammatory cytokine IL-8 enhances tumor cell proliferation, survival and exhibits potent pro-angiogenic activity, while also participating in the recruitment of lymphocytes, monocytes and neutrophils (<a href="#b59-ijo-67-04-05787" class="usa-link" aria-describedby="b59-ijo-67-04-05787">59</a>). Conversely, the anti-inflammatory cytokine IL-10 protects cancer cells from immune attack through potent immunosuppressive mechanisms (<a href="#b40-ijo-67-04-05787" class="usa-link" aria-describedby="b40-ijo-67-04-05787">40</a>,<a href="#b60-ijo-67-04-05787" class="usa-link" aria-describedby="b60-ijo-67-04-05787">60</a>).</p>
<p>Extensive research has focused on soluble factor-mediated molecular interactions between tumor cells and their microenvironment, collectively revealing the tip of the iceberg in intra-tumoral regulatory networks (<a href="#b3-ijo-67-04-05787" class="usa-link" aria-describedby="b3-ijo-67-04-05787">3</a>,<a href="#b61-ijo-67-04-05787" class="usa-link" aria-describedby="b61-ijo-67-04-05787">61</a>,<a href="#b62-ijo-67-04-05787" class="usa-link" aria-describedby="b62-ijo-67-04-05787">62</a>). Although the current understanding of the involvement of cytokine networks in TME communication remains incomplete, cytokines represent valuable therapeutic targets and biomarkers. This necessitates a deeper exploration of their signal transduction and regulatory functions in the TME.</p></section></section><section id="sec5"><h2 class="pmc_sec_title">3. Antibody arrays for secretome studies</h2>
<p>As major components of the cellular secretome, cytokines play pivotal roles in both physiological conditions and disease pathogenesis. Their dynamic balance reflects the pathological progression of cancer and reveals key disease mechanisms. Mass spectrometry (MS) technology analyzes proteins through the mass-to-charge ratio of ionized fragments and has developed into a routine detection tool for proteome research (<a href="#b63-ijo-67-04-05787" class="usa-link" aria-describedby="b63-ijo-67-04-05787">63</a>,<a href="#b64-ijo-67-04-05787" class="usa-link" aria-describedby="b64-ijo-67-04-05787">64</a>). However, MS still faces technical challenges in secretome analysis due to limitations such as the requirement for complex sample preprocessing (including protein enrichment and separation), insufficient sensitivity for detecting low-abundance proteins (such as inflammatory factors and growth factors) and poor reproducibility (<a href="#b65-ijo-67-04-05787" class="usa-link" aria-describedby="b65-ijo-67-04-05787">65</a>).</p>
<p>Affinity-based proteomic approaches offer superior sensitivity and specificity for detecting low-abundance proteins, allowing high-throughput analysis of multiple targets with minimal sample input. Critically, these techniques eliminate the need for complex sample preprocessing and have broad dynamic ranges, enabling the simultaneous detection of proteins with high and low abundance without extensive sample preparation (<a href="#b66-ijo-67-04-05787" class="usa-link" aria-describedby="b66-ijo-67-04-05787">66</a>). This makes affinity-based methods particularly well suited for analyzing clinical samples.</p>
<p>Antibody arrays are a type of protein microarray and represent a cornerstone technology in affinity-based proteomics. Derived from DNA microarrays, protein microarrays aim to detect proteins with high-throughput and sensitivity. In these systems, proteins such as antibodies, are immobilized on solid-phase carriers such as glass or nitrocellulose membranes to capture targets in samples (<a href="#b66-ijo-67-04-05787" class="usa-link" aria-describedby="b66-ijo-67-04-05787">66</a>,<a href="#b67-ijo-67-04-05787" class="usa-link" aria-describedby="b67-ijo-67-04-05787">67</a>). This technology is primarily categorized into forward-phase protein arrays (FPPA) and reverse-phase protein arrays (RPPA) based on the type of coated proteins (<a href="#f2-ijo-67-04-05787" class="usa-link">Fig. 2</a>) (<a href="#b68-ijo-67-04-05787" class="usa-link" aria-describedby="b68-ijo-67-04-05787">68</a>). The antibody array is the most common form of FPPA, in which specific antibodies are spotted onto a solid surface to detect protein concentrations in liquid samples. There are two main types of antibody arrays: Labeled-based arrays and sandwich-based arrays, each with distinct advantages and limitations.</p>
<figure class="fig xbox font-sm" id="f2-ijo-67-04-05787"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370358_ijo-67-04-05787-g01.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/357b/12370358/41e19160ee67/ijo-67-04-05787-g01.jpg" loading="lazy" height="354" width="677" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2-ijo-67-04-05787/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overview of main protein array platforms. Key features of two types of antibody arrays (left: sandwich-based; middle: label-based) alongside a reverse-phase protein array (right).</p></figcaption></figure><p>Sandwich-based antibody arrays employ pairs of antibodies for target detection: a capture antibody immobilized on the substrate and a detection antibody (often biotinylated) coupled to a signal reporter (such as a fluorescent label), allowing semi-quantitative or quantitative analysis (<a href="#b66-ijo-67-04-05787" class="usa-link" aria-describedby="b66-ijo-67-04-05787">66</a>,<a href="#b69-ijo-67-04-05787" class="usa-link" aria-describedby="b69-ijo-67-04-05787">69</a>). Due to the predefined antibody layout, fluorescence signals can be precisely mapped to specific target proteins. This dual-antibody setup, similar to other immunoassays, ensures high specificity and sensitivity. In contrast, label-based platforms pre-label sample proteins (for instance with biotin or fluorescent dyes), eliminating the need for detection antibodies. This bypasses challenges related to antibody pair availability and cross-reactivity, enabling the development of high-density arrays capable of detecting thousands of proteins simultaneously (<a href="#b70-ijo-67-04-05787" class="usa-link" aria-describedby="b70-ijo-67-04-05787">70</a>). Additionally, label-based arrays can be combined with specific antibodies or chemical reagents to detect post-translational protein modifications.</p>
<p>In RPPA systems, instead of immobilizing antibodies, protein samples themselves are directly spotted onto array surfaces. This sample-centric format allows analysis of a large number of samples in parallel on a single array. In cancer research, RPPAs have been widely used to measure protein expression and signaling pathway activation in tumor tissues and cells. They are also applied to detect autoantibodies against tumor-associated antigens in patient sera by immobilizing the relevant antigens on the array. However, RPPAs typically require experiment-specific customization, which limits their general applicability.</p></section><section id="sec6"><h2 class="pmc_sec_title">4. Recent findings on TME using antibody arrays</h2>
<p>The TME is highly heterogeneous, highlighting the complexity of the secreted protein signaling network within it, which necessitates a more comprehensive and systematic analysis to deconstruct. High-density antibody arrays have been successfully applied to secretome analysis across diverse sample types, including cell culture supernatants, biofluids and tissue lysates. These platforms reveal dysregulated protein patterns critical for interpreting the mechanisms underlying major diseases. In cancer research, precise detection of key secreted signaling proteins has advanced our understanding of the interactions between the TME and tumor cells and has enabled the discovery of novel therapeutic targets, demonstrating significant value from both research and clinical perspectives. In this section, we discuss key recent discoveries on the crosstalk between tumor cells and the TME utilizing antibody array technology, categorized into three major themes (<a href="#tI-ijo-67-04-05787" class="usa-link">Tables I</a> and <a href="#SD1-ijo-67-04-05787" class="usa-link">SI</a>).</p>
<section class="tw xbox font-sm" id="tI-ijo-67-04-05787"><h3 class="obj_head">Table I.</h3>
<div class="caption p"><p>Summary of findings in tumor microenvironment research using antibody arrays.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="bottom" align="left" rowspan="1" colspan="1">First author/s, year</th>
<th valign="bottom" align="center" rowspan="1" colspan="1">Tumor type</th>
<th valign="bottom" align="center" rowspan="1" colspan="1">Non-tumor cells</th>
<th valign="bottom" align="center" rowspan="1" colspan="1">Array results</th>
<th valign="bottom" align="center" rowspan="1" colspan="1">(Refs.)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chen, 2014</td>
<td valign="top" align="left" rowspan="1" colspan="1">NSCLC</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">IGF-2, HGF, and CXCL12 were identified as CAF-secreted factors.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b8-ijo-67-04-05787" class="usa-link" aria-describedby="b8-ijo-67-04-05787">8</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Bellei, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">NMSC</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulation of IL-6, IL-8, and other pro-inflammatory cytokines secretion in Onco-P20-treated CAFs was shown.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b9-ijo-67-04-05787" class="usa-link" aria-describedby="b9-ijo-67-04-05787">9</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Hu, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">NSCLC</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated differential expression of HGF and FGF-7 in three CAF subtypes was revealed.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b11-ijo-67-04-05787" class="usa-link" aria-describedby="b11-ijo-67-04-05787">11</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Su and Liu, 2014</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">High GM-CSF secretion in breast cancer cell secretome was shown.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b29-ijo-67-04-05787" class="usa-link" aria-describedby="b29-ijo-67-04-05787">29</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhou <em>et al</em>, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">MDSCs</td>
<td valign="top" align="left" rowspan="1" colspan="1">CXCL8 was identified as the most dysregulated chemokine in C-E-cad-knockdown cells.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b40-ijo-67-04-05787" class="usa-link" aria-describedby="b40-ijo-67-04-05787">40</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wei <em>et al</em>, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">CSCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">PAI-1 was identified as the most upregulated secretory cytokine in CAFs compared with normal fibroblasts.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b71-ijo-67-04-05787" class="usa-link" aria-describedby="b71-ijo-67-04-05787">71</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wei &amp; Cheng, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">CSCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Periostin, RGMB, Trappin-2, and PD-L1 were indicated as upregulated in CAFs.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b72-ijo-67-04-05787" class="usa-link" aria-describedby="b72-ijo-67-04-05787">72</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Sun, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">Omental adipocytes</td>
<td valign="top" align="left" rowspan="1" colspan="1">CCL2 was identified as a key adipocyte-secreted factor.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b73-ijo-67-04-05787" class="usa-link" aria-describedby="b73-ijo-67-04-05787">73</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ryan, 2019</td>
<td valign="top" align="left" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs, TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulated CCL2 secretion in geminin-overexpressing HMEs CM was identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b74-ijo-67-04-05787" class="usa-link" aria-describedby="b74-ijo-67-04-05787">74</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Han, 2022</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cervical cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">Hypoxic fibroblasts</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulated LTBR secretion in hypoxia fibroblasts was revealed.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b75-ijo-67-04-05787" class="usa-link" aria-describedby="b75-ijo-67-04-05787">75</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Huang <em>et al</em>, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">HCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">CCL7 was identified as the key cytokine reduced after TREM1 knockdown in TAMs.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b76-ijo-67-04-05787" class="usa-link" aria-describedby="b76-ijo-67-04-05787">76</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zheng &amp; Wang, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">CXCL1 was identified as the most upregulated chemokine in TAMs under mild psychological stress.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b77-ijo-67-04-05787" class="usa-link" aria-describedby="b77-ijo-67-04-05787">77</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Tatsuno, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">Osteosarcoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">IL-8 levels were indicated to markedly increase in co-culture CM compared with osteosarcoma cells or macrophage monocultures.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b78-ijo-67-04-05787" class="usa-link" aria-describedby="b78-ijo-67-04-05787">78</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Kim, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">CRC</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulated secretion of IL-6, TNF-α, and CXCL1 in M2-like TAMs was detected.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b79-ijo-67-04-05787" class="usa-link" aria-describedby="b79-ijo-67-04-05787">79</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Licarete, 2019</td>
<td valign="top" align="left" rowspan="1" colspan="1">Melanoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Reduced production of angiogenic proteins after PLP treatment was confirmed.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b80-ijo-67-04-05787" class="usa-link" aria-describedby="b80-ijo-67-04-05787">80</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wang <em>et al</em>, 2019</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutrophils</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated TIMP-1, GM-CSF, and angiogenin in tumor-infiltrating neutrophils compared with peripheral neutrophils were identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b81-ijo-67-04-05787" class="usa-link" aria-describedby="b81-ijo-67-04-05787">81</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Lee &amp; Chen, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">HNSCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Eosinophils</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulated levels of CCL2, IL-1β, IL-12, and other cytokines in activated eosinophils were identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b82-ijo-67-04-05787" class="usa-link" aria-describedby="b82-ijo-67-04-05787">82</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Benzing, 2019</td>
<td valign="top" align="left" rowspan="1" colspan="1">PDAC</td>
<td valign="top" align="left" rowspan="1" colspan="1">THP-1 monocyte-like cells</td>
<td valign="top" align="left" rowspan="1" colspan="1">TIMP-1 and TIMP-2 in THP-1 CM were detected.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b83-ijo-67-04-05787" class="usa-link" aria-describedby="b83-ijo-67-04-05787">83</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Li <em>et al</em>, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">LUAD</td>
<td valign="top" align="left" rowspan="1" colspan="1">Multiple immune cells</td>
<td valign="top" align="left" rowspan="1" colspan="1">TGF-β1 was identified as the most upregulated cytokine in UPP-1 highly expressed tumor cells.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b84-ijo-67-04-05787" class="usa-link" aria-describedby="b84-ijo-67-04-05787">84</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhu <em>et al</em>, 2019</td>
<td valign="top" align="left" rowspan="1" colspan="1">HCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Multiple immune cells</td>
<td valign="top" align="left" rowspan="1" colspan="1">TGF-β3, DcR3, and TGF-βRI were detected as upregulated in HCC tissues.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b85-ijo-67-04-05787" class="usa-link" aria-describedby="b85-ijo-67-04-05787">85</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Xie <em>et al</em>, 2018</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer, colon cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">Multiple immune cells</td>
<td valign="top" align="left" rowspan="1" colspan="1">Increased immune-activating and immuno-suppressive cytokines in AngII signaling blockage tumor cells were revealed.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b86-ijo-67-04-05787" class="usa-link" aria-describedby="b86-ijo-67-04-05787">86</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Jiang <em>et al</em>, 2022</td>
<td valign="top" align="left" rowspan="1" colspan="1">Osteosarcoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">Multiple immune cells</td>
<td valign="top" align="left" rowspan="1" colspan="1">Increased secretion of CCL5, CXCL9, and CXCL10 in c-Myc-inhibited K7M2 cell line was demonstrated.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b87-ijo-67-04-05787" class="usa-link" aria-describedby="b87-ijo-67-04-05787">87</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wang and Wang, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">CD8<sup>+</sup> T cells</td>
<td valign="top" align="left" rowspan="1" colspan="1">CXCL16 and CX3CL1 were confirmed as upregulated in CM of STK3-overexpressing ovarian cancer cells.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b88-ijo-67-04-05787" class="usa-link" aria-describedby="b88-ijo-67-04-05787">88</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhang and Cascio, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">HGSOC</td>
<td valign="top" align="left" rowspan="1" colspan="1">MSCs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated CXCL1, CXCL5, CCL7, and MIP-3 in macrophages treated with CM from MSC and tumor cell co-cultures were identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b89-ijo-67-04-05787" class="usa-link" aria-describedby="b89-ijo-67-04-05787">89</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Sheng, 2024</td>
<td valign="top" align="left" rowspan="1" colspan="1">PDAC</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Reduced IL-6, IL-8, and CXCL12 in TAK1-knockdown CAFs were identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b90-ijo-67-04-05787" class="usa-link" aria-describedby="b90-ijo-67-04-05787">90</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Nakamura, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">Melanoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">RAS-mediated CCL5 production in fibroblasts was identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b91-ijo-67-04-05787" class="usa-link" aria-describedby="b91-ijo-67-04-05787">91</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">SenGupta, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">TNBC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutrophils</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated CXCL1, CXCL2, CXCL3, and TGF-β levels in TNBC-derived CM compared with ER<sup>+</sup> cells-derived CM were detected.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b92-ijo-67-04-05787" class="usa-link" aria-describedby="b92-ijo-67-04-05787">92</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ogawa and Yamamoto, 2019</td>
<td valign="top" align="left" rowspan="1" colspan="1">CRC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutrophils</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated CXCL1/8 in SMAD4<sup>−</sup> SW837 cells and increased CXCL8 in neutrophils exposed to SMAD4<sup>−</sup> cell CM were identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b93-ijo-67-04-05787" class="usa-link" aria-describedby="b93-ijo-67-04-05787">93</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Germann, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">CRC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutrophils</td>
<td valign="top" align="left" rowspan="1" colspan="1">MMP-9 and RELMB were identified as differentially secreted in T cell-neutrophil co-cultures.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b94-ijo-67-04-05787" class="usa-link" aria-describedby="b94-ijo-67-04-05787">94</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chan, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">PAAD</td>
<td valign="top" align="left" rowspan="1" colspan="1">Neutrophils</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulated CXCL2, CTACK, and P-Selectin in melatonin-treated tumor cell-derived CM were found.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b95-ijo-67-04-05787" class="usa-link" aria-describedby="b95-ijo-67-04-05787">95</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Su <em>et al</em>, 2018</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated IL-6/IL-8 secretion in CD10<sup>+</sup>GPR77<sup>+</sup> CAFs was shown.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b96-ijo-67-04-05787" class="usa-link" aria-describedby="b96-ijo-67-04-05787">96</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zeng <em>et al</em>, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs, CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">CCL18, IL-6, and IL-8 were found upregulated in <em>in-vitro</em>-cultured chemoresistant tumor tissues.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b97-ijo-67-04-05787" class="usa-link" aria-describedby="b97-ijo-67-04-05787">97</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Papaccio <em>et al</em>, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">Melanoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Elevated IL-6, IL-8, IL-7, CCL11, and TIMP-2 in CAFs compared with normal fibroblasts were indicated.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b98-ijo-67-04-05787" class="usa-link" aria-describedby="b98-ijo-67-04-05787">98</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Zhou, 2016</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">A spectrum of secreted proteins derived from cisplatin-treated CAFs including CCL5 were detected.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b99-ijo-67-04-05787" class="usa-link" aria-describedby="b99-ijo-67-04-05787">99</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Che, 2018</td>
<td valign="top" align="left" rowspan="1" colspan="1">ESCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Increased PAI-1 secretion by cisplatin-pretreated CAFs was found.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b100-ijo-67-04-05787" class="usa-link" aria-describedby="b100-ijo-67-04-05787">100</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chrisochoidou, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">Mesothelioma</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulated cytokines (e.g., IL-6, CXCL12) and growth factors (e.g., PDGFs, FGFs) in activated fibroblasts were identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b101-ijo-67-04-05787" class="usa-link" aria-describedby="b101-ijo-67-04-05787">101</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Wang <em>et al</em>, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">ccRCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">CCL5 was identified as a key factor in the SOX17-modulated interaction between ccRCC cells and TAMs.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b102-ijo-67-04-05787" class="usa-link" aria-describedby="b102-ijo-67-04-05787">102</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Liu <em>et al</em>, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">CRC</td>
<td valign="top" align="left" rowspan="1" colspan="1">TAMs</td>
<td valign="top" align="left" rowspan="1" colspan="1">GM-CSF, G-CSF, and IL-7 secretion upregulated in KRAS mutant cells were identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b103-ijo-67-04-05787" class="usa-link" aria-describedby="b103-ijo-67-04-05787">103</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Lo Re and Mazza, 2020</td>
<td valign="top" align="left" rowspan="1" colspan="1">HCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Tregs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Downregulation of 94 cytokines (including IL-6 and IL-8) in macroH2A1-knockdown cell secretome was detected.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b104-ijo-67-04-05787" class="usa-link" aria-describedby="b104-ijo-67-04-05787">104</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Guo <em>et al</em>, 2023</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">IL-6, FGF-9, MIF, and TNFRSF11 were identified as highly secreted factors by CAFs.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b105-ijo-67-04-05787" class="usa-link" aria-describedby="b105-ijo-67-04-05787">105</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Chu, 2014</td>
<td valign="top" align="left" rowspan="1" colspan="1">Cervical cancer</td>
<td valign="top" align="left" rowspan="1" colspan="1">CAFs</td>
<td valign="top" align="left" rowspan="1" colspan="1">High levels of growth factors (e.g., IGF-2, EGF, and GM-CSF) secreted by CAFs, and PDGF-AA and PDGF-BB secreted by HeLa cells were revealed.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b106-ijo-67-04-05787" class="usa-link" aria-describedby="b106-ijo-67-04-05787">106</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Cao and Yin, 2021</td>
<td valign="top" align="left" rowspan="1" colspan="1">HCC</td>
<td valign="top" align="left" rowspan="1" colspan="1">Non-parenchymal liver cells</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulated MMP-8 in irradiated NPCs was identified.</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b107-ijo-67-04-05787" class="usa-link" aria-describedby="b107-ijo-67-04-05787">107</a>)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Arshad, 2015</td>
<td valign="top" align="left" rowspan="1" colspan="1">Lung carcinoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">Fibroblasts</td>
<td valign="top" align="left" rowspan="1" colspan="1">Upregulated IL-6, bFGF, CXCL16, sTNF-R1, MMP2/3, and Pro-MMP9 in TC-1 secretome when co-cultured with fibroblasts were identified</td>
<td valign="top" align="center" rowspan="1" colspan="1">(<a href="#b108-ijo-67-04-05787" class="usa-link" aria-describedby="b108-ijo-67-04-05787">108</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tI-ijo-67-04-05787/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tfn1-ijo-67-04-05787"><p>AngII, angiotensin II; CAF, cancer-associated fibroblast; CCL, C-C motif chemokine ligand; ccRCC, clear cell renal cell carcinoma; CM, conditioned medium; CRC, colorectal cancer; CSCC, cutaneous squamous cell carcinoma; CX3CL1, C-X3-C motif chemokine ligand 1; CXCL, C-X-C motif chemokine ligand; DcR3, decoy receptor 3; EGF, epidermal growth factor; ER, estrogen receptor; ESCC, esophageal squamous cell carcinoma; FGF, fibroblast growth factor; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; GPR77, G-protein-coupled receptor 77; HCC, hepatocellular carcinoma; HGF, hepatocyte growth factor; HGSOC, high-grade serous ovarian cancer; HMEs, human mammary epithelial cells; HNSCC, head and neck squamous cell carcinoma; IGF-2, insulin-like growth factor 2; IL, interleukin; LTBR, lymphotoxin-beta receptor; LUAD, lung adenocarcinoma; MDSCs, myeloid-derived suppressor cells; MIF, macrophage migration inhibitory factor; MIP-3, macrophage inflammatory protein-3; MMP, matrix metalloproteinase; MSCs, mesenchymal stem cells; NSCLC, non-small cell lung cancer; NMSC, non-melanoma skin cancer; PAAD, pancreatic adenocarcinoma; PAI-1, plasminogen activator inhibitor-1; PDAC, pancreatic ductal adenocarcinoma; PDGF, platelet-derived growth factor; PD-L1, programmed Death-Ligand 1; PLP, peptide-loaded particles; RGMB, repulsive guidance molecule B; RELMB, resistin-like molecule beta; SOX17, SRY-box transcription factor 17; sTNF-R1, soluble tumor necrosis factor receptor 1; TAK1, TGF-beta-activated kinase 1; TAMs, tumor-associated macrophages; TGF-β, transforming growth factor-beta; TGFβRI, transforming growth factor-beta receptor I; TIMP, tissue inhibitor of metalloproteinases; TNBC, triple-negative breast cancer; TNF-α, tumor necrosis factor-alpha; TNFRSF11, tumor necrosis factor receptor superfamily member 11; Tregs, regulatory T cells; TREM1, triggering receptor expressed on myeloid cells 1; UPP-1, uridine phosphorylase-1.</p></div></div></section><section id="sec7"><h3 class="pmc_sec_title">TME on tumor progression and metastasis</h3>
<p>The TME is a dynamic ecosystem where stromal and immune cells interact with cancer cells through a complex network of secreted proteins, such as inflammatory mediators, chemokines and growth factors, to drive the development of tumorigenic phenotypes. Studies have made breakthroughs in exploring the molecular mechanisms underlying this process.</p>
<p>In a series of studies on cervical squamous cell carcinoma, Wei <em>et al</em> (<a href="#b71-ijo-67-04-05787" class="usa-link" aria-describedby="b71-ijo-67-04-05787">71</a>) investigated the tumor-promoting mechanisms of CAFs through two distinct signaling axes. First, CAF-derived plasminogen activator inhibitor-1 (PAI-1) was identified as promoting lymphatic metastasis by triggering EndoMT in lymphatic endothelial cells (LECs). This process was mediated through LDL receptor-related protein 1 (LRP1)-dependent activation of the AKT/ERK signaling pathway, ultimately facilitating tumor dissemination. This identifies the PAI-1/LRP1 axis as a potential therapeutic target for inhibiting metastasis. Parallel to this discovery, the team further identified periostin<sup>+</sup> CAFs as another critical mediator of lymphatic metastasis. Periostin secreted by these CAFs activated the integrin-FAK/Src signaling cascade in LECs, leading to phosphorylation and subsequent degradation of VE-cadherin. This disrupted LEC barrier integrity, facilitating tumor cell intravasation and dissemination (<a href="#b72-ijo-67-04-05787" class="usa-link" aria-describedby="b72-ijo-67-04-05787">72</a>). In addition to fibroblasts, Sun <em>et al</em> (<a href="#b73-ijo-67-04-05787" class="usa-link" aria-describedby="b73-ijo-67-04-05787">73</a>) demonstrated how omental adipocytes facilitate tumor peritoneal metastasis in ovarian cancer in a murine model. Adipocyte-secreted CCL2 bound to CCR2 on cancer cells, activating the PI3K/AKT/mTOR pathway, which upregulated hypoxia inducible factor-1α (HIF-1α) and VEGF-A secretion. This stimulated intra-tumor angiogenesis and tumor metastasis to the omentum. Blocking the CCL2/CCR2 axis represents a potential therapeutic strategy to prevent peritoneal metastasis in ovarian cancer. A complex bi-directional crosstalk between geminin-overexpressing (GemOE) triple-negative breast cancer (TNBC) cells and stromal cells was investigated as a driver of metastasis. GemOE-cells secreted acetylated HMGB1, which activated receptor for advanced glycation end-products (RAGE) and CXCR4 expression on mesenchymal stem cells (MSCs) and recruited them into tumors. These MSCs differentiated into CAFs and secreted S100A4, which reciprocally stimulated GemOE-cells to release CCL2, attracting and polarizing macrophages into M2-TAMs. Gas6 secreted by the TAMs combined with AXL on GemOE cells and synergized with RAGE signaling to amplify cancer stemness, EMT and CD151/α3β1-integrin-mediated interactions, enhancing invasiveness (<a href="#b74-ijo-67-04-05787" class="usa-link" aria-describedby="b74-ijo-67-04-05787">74</a>). While CAFs typically promote tumor growth, Han <em>et al</em> (<a href="#b75-ijo-67-04-05787" class="usa-link" aria-describedby="b75-ijo-67-04-05787">75</a>) revealed that hypoxic fibroblasts demonstrated opposing effects. Conditioned medium (CM) from hypoxic dermal fibroblasts (H-CM) suppressed cervical cancer cell (HeLa) viability by enhancing apoptosis via caspase-3/7 activation, mitochondrial dysfunction and G<sub>0</sub>/G<sub>1</sub> arrest. Proteomics analysis identified lymphotoxin-beta receptor (LTBR), a member of the TNF receptor family, as a key factor upregulated in H-CM, which suppressed HeLa cell proliferation. These findings suggest microenvironment-dependent fibroblast plasticity in regulating malignant progression (<a href="#b75-ijo-67-04-05787" class="usa-link" aria-describedby="b75-ijo-67-04-05787">75</a>).</p>
<p>TAMs are pivotal drivers of tumor progression, primarily through their secretion of cytokines and chemokines that promote immunosuppressive microenvironments and metastatic cascades. Huang <em>et al</em> (<a href="#b76-ijo-67-04-05787" class="usa-link" aria-describedby="b76-ijo-67-04-05787">76</a>) demonstrated that TAMs expressing high levels of triggering receptor expressed on myeloid cells 1 (TREM1) are key contributors to EMT and metastasis in hepatocellular carcinoma (HCC). The authors identified CCL7 as a key downstream effector secreted by TREM1<sup>+</sup> TAMs that drives these effects. These findings suggest TREM1 or CCL7 as potential targets to disrupt EMT and metastasis in HCC. Furthermore, TREM1 expression positively associated with elevated levels of programmed death ligand 1 (PD-L1) and cytotoxic T lymphocyte associated protein 4 (CTLA-4), linking CCL7-driven EMT to immunosuppressive TME remodeling (<a href="#b76-ijo-67-04-05787" class="usa-link" aria-describedby="b76-ijo-67-04-05787">76</a>). In breast cancer models, Zheng <em>et al</em> (<a href="#b77-ijo-67-04-05787" class="usa-link" aria-describedby="b77-ijo-67-04-05787">77</a>) demonstrated that chronic unpredictable mild psychological stress activates glucocorticoid receptor (GR) signaling in TAMs, leading to increased secretion of CXCL1. This chemokine facilitated MDSC recruitment via CXCR2, enhancing their immunosuppressive capacity to inhibit CD8<sup>+</sup> T cell cytotoxicity and promote pre-metastatic niche formation. Therefore, targeting GR signaling in TAMs or the CXCL1-CXCR2 axis represents a potential therapeutic strategy to counteract stress-induced metastasis and immunosuppression in breast cancer. In osteosarcoma, a group of Iba1<sup>+</sup>/CD163<sup>+</sup> TAMs were found to enhance tumor progression and lung metastasis. Using antibody arrays, the authors confirmed the CM of tumor cells and TAMs co-cultures enriched with IL-8, which markedly enhanced osteosarcoma cell proliferation, migration and invasion through the FAK pathway (<a href="#b78-ijo-67-04-05787" class="usa-link" aria-describedby="b78-ijo-67-04-05787">78</a>). Macrophage polarization and cytokine release are influenced by bi-directional crosstalk with tumor-derived factors, which further enhance tumor progression. Kim <em>et al</em> (<a href="#b79-ijo-67-04-05787" class="usa-link" aria-describedby="b79-ijo-67-04-05787">79</a>) highlighted that colorectal cancer (CRC)-derived CD133<sup>+</sup> microvesicles (MVs) differentiate macrophages into an M2-like phenotype within the TME. CD133<sup>+</sup> MVs triggered IL-6 secretion from TAMs, which subsequently activated the STAT3 pathway in CRC cells, thereby enhancing their EMT and invasion. IL-6/STAT3 activation further established a feedback loop, reinforcing CD133 expression in cancer cells and establishing an immunosuppressive TME conducive to CRC progression. Targeting TAMs is a promising strategy to enhance anti-tumor effects. As demonstrated by Licarete <em>et al</em> (<a href="#b80-ijo-67-04-05787" class="usa-link" aria-describedby="b80-ijo-67-04-05787">80</a>), prednisolone phosphate (PLP) enhances doxorubicin (DOX) efficacy against B16.F10 melanoma cells by targeting TAMs. PLP suppresses TAM-mediated angiogenesis by downregulating pro-angiogenic factors (FGF-2, VEGF, G-CSF, IL-1β and TNF-α), thereby disrupting the TME supporting melanoma growth. Combined PLP with DOX synergistically inhibits melanoma proliferation and induces apoptosis, linked to reduced oxidative stress and potentiated anti-angiogenic effects. However, the M2 immunosuppressive phenotype and IL-10 and arginase-1 (Arg-1) secretion remains unaffected, highlighting TAM angiogenic pathways as the primary mechanism.</p>
<p>Other immune cells within the TME also play a role in regulating tumor progression through distinct secretory programs. In TNBC, tumor-infiltrating neutrophils are engaged in a self-reinforcing loop with cancer cells via tissue inhibitor of metalloproteinase-1 (TIMP-1) and CD90 interactions (<a href="#b81-ijo-67-04-05787" class="usa-link" aria-describedby="b81-ijo-67-04-05787">81</a>). Antibody array screening demonstrated that these neutrophils secrete elevated TIMP-1, which drove twist-mediated EMT in tumor cells. Reciprocally, EMT-transformed CD90<sup>+</sup> tumor cells enhanced TIMP-1 production in neutrophils through CD90-Mac-1 interactions, amplifying metastatic potential of the tumor (<a href="#b81-ijo-67-04-05787" class="usa-link" aria-describedby="b81-ijo-67-04-05787">81</a>). Lee <em>et al</em> (<a href="#b82-ijo-67-04-05787" class="usa-link" aria-describedby="b82-ijo-67-04-05787">82</a>) demonstrated that eosinophils drove metastasis through cytokine-mediated immunosuppression and vascular remodeling in head and neck squamous cell carcinoma (HNSCC). Tumor-associated tissue eosinophilia (TATE) was found to be associated with aggressive tumor features such as angiogenesis and lymph node metastasis in HNSCC, with TATE-rich tumors exhibiting increased CD4<sup>+</sup>Foxp3<sup>+</sup> Tregs, exhausted CD8<sup>+</sup>PD1<sup>+</sup> T cells and reduced cytotoxic lymphocytes, collectively fostering an immunosuppressive niche that accelerates tumor progression. CCL2 was identified as a key eosinophil-derived factor promoting tumor cell migration and EMT (<a href="#b82-ijo-67-04-05787" class="usa-link" aria-describedby="b82-ijo-67-04-05787">82</a>). While typically associated with immunosuppression, Benzing <em>et al</em> (<a href="#b83-ijo-67-04-05787" class="usa-link" aria-describedby="b83-ijo-67-04-05787">83</a>) reported that undifferentiated monocyte-like suppresses pancreatic ductal adenocarcinoma (PDAC) invasiveness. Co-culturing PDAC cells with monocyte-like THP-1 markedly suppressed invadopodia formation and matrix degradation. Proteomic analysis of THP-1 CM identified high levels of TIMP-2, which selectively inhibits MT1-MMP (MMP-14), an enzyme critical for invadopodia function.</p></section><section id="sec8"><h3 class="pmc_sec_title">Immune microenvironment remodeling through secreted proteins</h3>
<p>The balance between tumor-promoting and tumor-suppressing immune responses is critical for tumor survival and involves multiple signaling pathways modulated by secreted factors derived from tumor cells, immune cells and non-neoplastic stromal cells within the TME. However, due to the complexity of this dynamic process, the underlying mechanisms remain incompletely understood. Li <em>et al</em> (<a href="#b84-ijo-67-04-05787" class="usa-link" aria-describedby="b84-ijo-67-04-05787">84</a>) identified the critical role of uridine phosphorylase 1 (UPP1), highly expressed in lung adenocarcinoma (LUAD) cells, in shaping an immunosuppressive TME. UPP1 upregulation in tumor cells elevated TGF-β1 secretion, which promoted Treg differentiation, CD8<sup>+</sup> T cell exhaustion and macrophage polarization toward an M2 phenotype via paracrine signaling. Additionally, UPP1 activated the PI3K/AKT/mTOR pathway to enhance PD-L1 expression on LUAD cells, further impairing T cell cytotoxic function. Similarly, TGF-β3 overexpression in HCC cells was shown to activate the SMAD2/3-Sp1 axis, thereby upregulating decoy receptor 3 (DcR3), which inhibits pro-inflammatory signaling by binding to the LIGHT ligand on activated CD4<sup>+</sup> T cells. DcR3 further promoted the differentiation of CD4<sup>+</sup> T cells into Th2 and Treg cells while suppressing Th1 polarization, thereby impairing anti-tumor immunity in HCC (<a href="#b85-ijo-67-04-05787" class="usa-link" aria-describedby="b85-ijo-67-04-05787">85</a>). Xie <em>et al</em> (<a href="#b86-ijo-67-04-05787" class="usa-link" aria-describedby="b86-ijo-67-04-05787">86</a>) demonstrated that hypoxic tumor cells in mouse breast and colon cancer models produce angiotensin II (AngII) via a hypoxia-lactate-chymase-dependent axis, fostering an immunosuppressive TME characterized by increased infiltration of Tregs, TAMs, CAFs and MDSCs, alongside reduced recruitment of CD8<sup>+</sup> effector T cells. Blocking AngII signaling reversed this immunosuppressive TME and markedly upregulated immune-activating cytokines (such as IL-7, IL-20 and CXCL11) while downregulating immunosuppressive cytokines (such as IL-10, GM-CSF and CCL28) in 4T1 breast cancer cells. Since the immunosuppressive microenvironment is essential for tumor persistence, its modulation represents a promising therapeutic strategy. Jiang <em>et al</em> (<a href="#b87-ijo-67-04-05787" class="usa-link" aria-describedby="b87-ijo-67-04-05787">87</a>) revealed c-Myc targeting as a strategy to overcome immune suppression in osteosarcoma. c-Myc inhibition via JQ-1 upregulated T cell-recruiting chemokines (CCL5, CXCL9 and CXCL10), thereby enhancing cytotoxic T cell infiltration. Simultaneously, c-Myc inhibition upregulated CD40 on dendritic cells (DCs) and activated CD40/CD40L costimulatory signaling to promote DC-T cell interaction and cytotoxic T cell activation. These immune-enhancing effects, rather than direct anti-proliferative actions, drove tumor regression and prolonged overall survival in murine models. Wang <em>et al</em> (<a href="#b88-ijo-67-04-05787" class="usa-link" aria-describedby="b88-ijo-67-04-05787">88</a>) found that STK3 expression is epigenetically suppressed via promoter hypermethylation in ovarian cancer, associated with poor patient prognosis. Overexpression of STK3 in ovarian cancer cells activated the NF-κB signaling pathway, leading to upregulated CXCL16 and CX3CL1. These chemokines facilitated the recruitment of CD8<sup>+</sup> T cells and markedly inhibited tumor cell proliferation, migration and invasion while promoting apoptosis. These findings highlighted the role of STK3 in counteracting immune suppression.</p>
<p>High-stromal tumors, characterized by elevated fibroblast and MSC content, exhibit a distinct immune landscape marked by reduced infiltration of effector cells. In high-grade serous ovarian carcinoma, CXCL12 overexpression was found in epithelial-like tumor cells and cancer-associated MSCs and was shown to drive immune exclusion by binding to CXCR4 receptors on cytotoxic CD8<sup>+</sup> T cells and NK cells, sequestering these effector cells in stromal compartments (<a href="#b89-ijo-67-04-05787" class="usa-link" aria-describedby="b89-ijo-67-04-05787">89</a>). This CXCL12-CXCR4 axis impaired anti-tumor immunity by suppressing granzyme B and IFN-γ production in CD8<sup>+</sup> T cells while upregulating immunosuppressive cytokines such as CXCL1, CXCL5 and CXCL13 in myeloid cells (<a href="#b89-ijo-67-04-05787" class="usa-link" aria-describedby="b89-ijo-67-04-05787">89</a>). Similarly, Sheng <em>et al</em> (<a href="#b90-ijo-67-04-05787" class="usa-link" aria-describedby="b90-ijo-67-04-05787">90</a>) identified TAK1<sup>+</sup> CAFs as playing a critical role in shaping the immunosuppressive microenvironment of PDAC. TAK1<sup>+</sup> CAFs predominantly exhibit an inflammatory phenotype and serve as major sources of CXCL12 and IL-6, which recruit MDSCs and polarize macrophages toward M2 phenotypes, while also excluding CD8<sup>+</sup> T cells from tumor nests. Notably, TAK1 inhibition shifted CAFs toward a tumor-suppressive myo-fibroblastic phenotype, which suppressed EMT and tumor cell invasion via downregulation of MAPK and NF-κB pathways. Furthermore, angiotensin-stimulated human and mouse fibroblasts were found to secrete CCL5 as a key immunosuppressive mediator in melanoma, which simultaneously reduced intra-tumoral CD8<sup>+</sup> T cell infiltration and promoted Treg recruitment via CCR5 (<a href="#b91-ijo-67-04-05787" class="usa-link" aria-describedby="b91-ijo-67-04-05787">91</a>).</p>
<p>A growing number of studies have reported that neutrophils can be recruited to tumor tissues by specific cytokines and chemokines, undergo functional polarization and exert dual regulatory effects in TME immunomodulation. SenGupta <em>et al</em> (<a href="#b92-ijo-67-04-05787" class="usa-link" aria-describedby="b92-ijo-67-04-05787">92</a>) demonstrated that TNBC recruited neutrophils via tumor-derived factors. Antibody array screening identified a distinct secreted profile in aggressive TNBC cells compared with ER<sup>+</sup> cells, characterized by elevated production of TGF-β and CXCR2 ligands (e.g., CXCL1, CXCL2 and CXCL3). These factors synergistically promoted neutrophil chemotaxis and polarization via TGF-β/SMAD3 signaling and the CXCR2-Gi pathway. Complementing this, Ogawa <em>et al</em> (<a href="#b93-ijo-67-04-05787" class="usa-link" aria-describedby="b93-ijo-67-04-05787">93</a>) revealed that loss of SMAD4, a tumor suppressor, in CRC cells triggered massive production of CXCL1 and CXCL8 via IκB kinase 2 and GSK-3β pathways, leading to accumulation of CXCR2<sup>+</sup> neutrophils in tumors. These neutrophils further amplified CXCL1 and CXCL8 production in the TME, while polarizing neutrophils toward pro-angiogenic and immunosuppressive phenotypes marked by MMP-2 and 9, Arg-1 and indoleamine 2,3-dioxygenase expression. Germann <em>et al</em> (<a href="#b94-ijo-67-04-05787" class="usa-link" aria-describedby="b94-ijo-67-04-05787">94</a>) further identified that tumor-infiltrating neutrophils play a pivotal role in forming an immunosuppressive microenvironment in CRC. These neutrophils release MMP-9 to proteolytically convert latent TGF-β into its bio-active form. Activated TGF-β subsequently exerts dual immunosuppressive effects by suppressing anti-tumor effector T cells and promoting Treg expansion. Neutrophil depletion or MMP inhibition in mice reduces TGF-β signaling, enhances CD8<sup>+</sup> T cell infiltration and diminishes the tumor burden. Conversely, Chan <em>et al</em> (<a href="#b95-ijo-67-04-05787" class="usa-link" aria-describedby="b95-ijo-67-04-05787">95</a>) reported that neutrophils acquire an anti-tumor phenotype in pancreatic adenocarcinoma (PAAD) with melatonin supplementation. Melatonin stimulates CXCL2 secretion from tumor cells, promoting neutrophil infiltration and polarization toward an N1-like phenotype in PAAD, characterized by CD11b<sup>+</sup>Ly6G<sup>+</sup>. These neutrophils exhibit elevated ROS and form neutrophil extracellular traps, inducing tumor cell death through cell-contact-dependent NETosis.</p></section><section id="sec9"><h3 class="pmc_sec_title">TME in promoting therapeutic resistance</h3>
<p>Therapeutic resistance constitutes a fundamental issue limiting the efficacy of chemotherapy in cancer patients. Besides neoplastic cells, the TME mediates therapy resistance through direct intercellular contact within TME components or dynamic alterations in local secreted factors. CAFs exhibit functional heterogeneity in shaping chemoresistance through distinct secreted profiles that sustain cancer stemness and activate survival pathways. Su <em>et al</em> (<a href="#b96-ijo-67-04-05787" class="usa-link" aria-describedby="b96-ijo-67-04-05787">96</a>) identified a pivotal CD10<sup>+</sup>GPR77<sup>+</sup> CAF subset in breast cancers that establishes a chemoresistance niche by driving persistent NF-κB activation through GPR77-mediated complement signaling. This signaling axis promotes IL-6 and IL-8 secretion in CAFs, which enhances cancer stemness and upregulates ABCG2-mediated drug efflux in cancer cells. Moreover, the recruitment and activation of this CAF subset were found to be dynamically regulated by crosstalk with macrophages (<a href="#b97-ijo-67-04-05787" class="usa-link" aria-describedby="b97-ijo-67-04-05787">97</a>). M2-polarized TAMs secrete CCL18, which binds to the PITPNM3 receptor on normal breast fibroblasts, inducing their differentiation into CD10<sup>+</sup>GPR77<sup>+</sup> CAFs. In clinical cohorts, a strong association between CCL18<sup>+</sup> TAM infiltration and CD10<sup>+</sup>GPR77<sup>+</sup> CAF density across breast cancer subtypes was confirmed, highlighting the role of immune-stromal cell crosstalk in amplifying cancer chemoresistance (<a href="#b97-ijo-67-04-05787" class="usa-link" aria-describedby="b97-ijo-67-04-05787">97</a>). Further demonstrating the role of CAF secretory heterogeneity in chemoresistance, Hu <em>et al</em> (<a href="#b11-ijo-67-04-05787" class="usa-link" aria-describedby="b11-ijo-67-04-05787">11</a>) established a living biobank of patient-derived CAFs in non-small cell lung cancer and used high-throughput antibody arrays to functionally classify CAFs into three subtypes based on their secreted profiles and resistance mechanisms. Subtype I CAFs secreted high levels of HGF and FGF-7, activating MET/FGFR bypass signaling to confer robust resistance to EGFR/ALK inhibitors. Subtype II CAFs predominantly secreted FGF-7, mediating moderate FGFR-dependent resistance, while subtype III CAFs showed minimal protective capacity. This classification enabled subtype-specific therapeutic strategies: Dual MET/FGFR inhibition overcame subtype I-mediated resistance, whereas subtype II required only FGFR blockade. In melanoma, Papaccio <em>et al</em> (<a href="#b98-ijo-67-04-05787" class="usa-link" aria-describedby="b98-ijo-67-04-05787">98</a>) revealed a pivotal role of CAFs in suppressing chemotherapy-induced cytotoxicity via secretion of IL-6 and IL-8. CAF-derived supernatants enriched in pro-tumorigenic growth factors (HGF, FGF-2 and VEGF) accelerated melanoma cell migration and induced sustained activation of FAK signaling in treated tumor cells. In ovarian cancer, cisplatin-treated CAFs secrete elevated CCL5, which activates STAT3 and PI3K/AKT pathways in tumor cells, attenuating cisplatin cytotoxicity both <em>in vitro</em> and <em>in vivo</em> by enhancing Bcl-2 expression and suppressing pro-apoptotic markers (<a href="#b99-ijo-67-04-05787" class="usa-link" aria-describedby="b99-ijo-67-04-05787">99</a>). Additionally, Che <em>et al</em> (<a href="#b100-ijo-67-04-05787" class="usa-link" aria-describedby="b100-ijo-67-04-05787">100</a>) identified cisplatin-induced PAI-1 secretion by esophageal CAFs as a key mediator of AKT and ERK1/2 activation in esophageal squamous cell carcinoma (ESCC). PAI-1 suppresses caspase-3 activity and ROS accumulation, attenuating apoptosis in a paracrine manner, with clinical data linking high stromal PAI-1 expression to poor progression-free survival in ESCC patients. Chemoresistance development also involves remodeling of ECM. Chrisochoidou <em>et al</em> (<a href="#b101-ijo-67-04-05787" class="usa-link" aria-describedby="b101-ijo-67-04-05787">101</a>) showed that mesothelioma-activated fibroblasts deposit collagen- and tenascin-enriched ECM, which sequesters TGF-β and activates PI3K/mTOR/SRC pathways to promote resistance to cisplatin and pemetrexed. This fibrotic niche recruits naïve fibroblasts through chemo-attractants such as CHI3L1 and angiopoietin, establishing a self-sustaining resistance loop.</p>
<p>Tumor-associated immune cells and neoplastic cells cooperatively establish chemoresistance through secreted protein networks that reprogram the TME. In clear cell renal cell carcinoma, Wang <em>et al</em> (<a href="#b102-ijo-67-04-05787" class="usa-link" aria-describedby="b102-ijo-67-04-05787">102</a>) identified a self-reinforcing loop where SOX17 loss activated YAP/TEAD1 signaling, driving CCL5 secretion to recruit and polarize M2-like TAMs. These TAMs, in turn, suppressed SOX17 via CCR5/STAT3 signaling, amplifying CCL5 production and fostering resistance to tyrosine kinase inhibitors. Similarly, in KRAS-mutant CRC, Liu <em>et al</em> (<a href="#b103-ijo-67-04-05787" class="usa-link" aria-describedby="b103-ijo-67-04-05787">103</a>) demonstrated that mutant KRAS stabilizes HIF-1α via ROS-mediated prolyl hydroxylase inhibition, leading to overexpression of colony GM-CSF and lactate. These factors synergistically polarized macrophages toward an immunosuppressive CD206<sup>high</sup>/HLA-DR<sup>low</sup> phenotype characterized by anti-inflammatory cytokine secretion, which shielded tumor cells from cetuximab-induced apoptosis. The metabolic reprogramming of CRC cells further reinforced TAM-mediated resistance, as lactate enhanced GM-CSF-driven immunosuppression. In HCC, macroH2A1 loss was demonstrated to enhance cancer cell stemness marked by reduced IL-6 and IL-8 secretion. This cytokine-depleted secretome reprogramed neighboring tumor cells to adopt chemoresistance and expanded immunosuppressive CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> Tregs, linking epigenetic dysregulation to paracrine-mediated immune evasion (<a href="#b104-ijo-67-04-05787" class="usa-link" aria-describedby="b104-ijo-67-04-05787">104</a>).</p>
<p>Resistance to radiotherapy also involves stromal secreted factors that alter tumor cell behavior. Guo <em>et al</em> (<a href="#b105-ijo-67-04-05787" class="usa-link" aria-describedby="b105-ijo-67-04-05787">105</a>) demonstrated that CAFs in breast cancer secrete IL-6 to promote radioresistance. CAF-derived IL-6 enhanced post-irradiation survival and proliferation of cancer cells <em>in vitro</em>, while murine co-injection models revealed that IL-6/STAT3 signaling diminished radiation efficacy. Chu <em>et al</em> (<a href="#b106-ijo-67-04-05787" class="usa-link" aria-describedby="b106-ijo-67-04-05787">106</a>) found that CAFs enhanced cervical cancer growth and resistance to radiation. CM from CAFs alone or from CAF-HeLa co-cultures suppressed DNA damage response genes (GADD45α, BTG2) and promoted p38 phosphorylation in HeLa cells following irradiation. Using antibody arrays, the authors identified distinct cytokine profiles in CAFs and HeLa cells: CAFs secreted high levels of IGF-2, EGF and FGF-4, whereas HeLa cells produced platelet-derived growth factor (PDGF)-AA and PDGF-BB, suggesting that this bidirectional crosstalk establishes a growth factor-enriched, radioprotective microenvironment through integrated growth factor signaling. Beyond fibroblasts, Cao <em>et al</em> (<a href="#b107-ijo-67-04-05787" class="usa-link" aria-describedby="b107-ijo-67-04-05787">107</a>) showed that sub-lethally irradiated non-parenchymal liver cells in HCC elevated MMP-8 production, which suppressed AMPK phosphorylation and activated mTOR signaling in HCC cells, driving TME remodeling and metastatic progression. Arshad <em>et al</em> (<a href="#b108-ijo-67-04-05787" class="usa-link" aria-describedby="b108-ijo-67-04-05787">108</a>) reported that simultaneous irradiation of stromal and tumor cells further modulates secretory dynamics. Irradiated wild-type fibroblasts secreted TGF-β1 to induce EMT in lung carcinoma cells, enhancing migration via Vimentin and Snail upregulation, while RhoB-deficient fibroblasts promoted pro-metastatic MMP secretion. Notably, co-irradiation of tumor and stromal cells suppressed TGF-β1 and MMP release, in contrast to stromal-only irradiation. RhoB-deficient fibroblasts additionally upregulated IL-6 and FGF-2 in tumor cells, suggesting genotype-specific shifts in paracrine signaling that may influence immune modulation.</p></section></section><section id="sec10"><h2 class="pmc_sec_title">5. Summary</h2>
<p>The TME constitutes a complex ecosystem composed of cellular components (such as stromal cells, infiltrating immune cells and vascular and lymphatic networks) and non-cellular elements, including ECM components and soluble factors such as inflammatory factors, growth factors, chemokines and MMPs. Dynamic remodeling of the TME during tumor progression is regulated by intricate inter-cellular communication networks. Crosstalk among TME cell populations occurs via both direct cell-cell contact and signaling mediated by secreted factors. These complex communication networks form positive feedback loops that sustain tumor cell proliferation, facilitate invasion and immune evasion and enable resistance to therapy, ultimately influencing disease progression. An in-depth understanding of this cytokine-driven signaling is crucial to deciphering tumor-TME interactions.</p>
<p>Antibody arrays have emerged as powerful tools for exploring the regulatory mechanisms within the TME. Unlike traditional protein detection methods, antibody arrays enable high-throughput, multiplex detection of low-abundance secreted proteins using minimal sample input. By rapidly and accurately analyzing the secretion profiles, these platforms reveal dynamic alterations in TME signaling networks, elucidating cytokine-mediated mechanisms underlying tumor progression, drug resistance and immune escape. These findings not only deepen our understanding of TME heterogeneity but also inform the development of combination therapies targeting both tumor cells and their supportive microenvironment.</p>
<p>By mapping complex signaling cascades between tumor cells and stromal components to identify key cytokines, researchers can more effectively prioritize therapeutic targets. In addition, understanding the heterogeneity of the TME is essential for personalizing anti-tumor strategies and advancing precision oncology. This includes using antibody arrays to screen for predictive biomarkers in drug-resistant patients or to guide drug selection based on patient-specific TME secreted profiles. These applications hold promise for transforming cancer treatment paradigms.</p></section><section id="sec11"><h2 class="pmc_sec_title">Supplementary Data</h2>
<section class="sm xbox font-sm" id="SD1-ijo-67-04-05787"><div class="media p" id="d67e826"><div class="caption">
<a href="/articles/instance/12370358/bin/IJO-67-4-05787-Supplementary_Data.xlsx" data-ga-action="click_feat_suppl" class="usa-link">IJO-67-4-05787-Supplementary_Data.xlsx</a><sup> (11.5KB, xlsx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The present study was supported by RayBiotech innovative research fund, National Key R&amp;D Program of China (grant nos. 2024YFA1307601, 2024YFA1307602 and 2024YFA1307603). Guangzhou 2024 Annual Special Project on Agricultural and Social Development Science and Technology (grant nos. 2024B03J1332 and 2024B03J1249).</p></section><section id="sec12"><h2 class="pmc_sec_title">Availability of data and materials</h2>
<p>Not applicable.</p></section><section id="sec13"><h2 class="pmc_sec_title">Authors' contributions</h2>
<p>YW wrote the manuscript and constructed figures and tables. SL wrote the manuscript. HD and RPH revised the manuscript. SL and RPH conceived the study. Data authentication is not applicable. All authors have read and approved the final manuscript.</p></section><section id="sec14"><h2 class="pmc_sec_title">Ethics approval and consent to participate</h2>
<p>Not applicable.</p></section><section id="sec15"><h2 class="pmc_sec_title">Patient consent for publication</h2>
<p>Not applicable.</p></section><section id="sec16"><h2 class="pmc_sec_title">Competing interests</h2>
<p>The authors declare that they have no competing interests.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="b1-ijo-67-04-05787">
<span class="label">1.</span><cite>Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–1437. doi: 10.1038/nm.3394.</cite> [<a href="https://doi.org/10.1038/nm.3394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3954707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24202395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Microenvironmental%20regulation%20of%20tumor%20progression%20and%20metastasis&amp;author=DF%20Quail&amp;author=JA%20Joyce&amp;volume=19&amp;publication_year=2013&amp;pages=1423-1437&amp;pmid=24202395&amp;doi=10.1038/nm.3394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b2-ijo-67-04-05787">
<span class="label">2.</span><cite>Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP, Gangadaran P, Ahn BC. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun (Lond) 2023;43:525–561. doi: 10.1002/cac2.12416.</cite> [<a href="https://doi.org/10.1002/cac2.12416" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10174093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37005490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Commun%20(Lond)&amp;title=Tumor%20microenvironment%20signaling%20and%20therapeutics%20in%20cancer%20progression&amp;author=A%20Goenka&amp;author=F%20Khan&amp;author=B%20Verma&amp;author=P%20Sinha&amp;author=CC%20Dmello&amp;volume=43&amp;publication_year=2023&amp;pages=525-561&amp;pmid=37005490&amp;doi=10.1002/cac2.12416&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b3-ijo-67-04-05787">
<span class="label">3.</span><cite>Zhang X, Ma H, Gao Y, Liang Y, Du Y, Hao S, Ni T. The tumor microenvironment: Signal transduction. Biomolecules. 2024;14:438. doi: 10.3390/biom14040438.</cite> [<a href="https://doi.org/10.3390/biom14040438" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11048169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38672455/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=The%20tumor%20microenvironment:%20Signal%20transduction&amp;author=X%20Zhang&amp;author=H%20Ma&amp;author=Y%20Gao&amp;author=Y%20Liang&amp;author=Y%20Du&amp;volume=14&amp;publication_year=2024&amp;pages=438&amp;pmid=38672455&amp;doi=10.3390/biom14040438&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b4-ijo-67-04-05787">
<span class="label">4.</span><cite>Khosravi G, Mostafavi S, Bastan S, Ebrahimi N, Gharibvand RS, Eskandari N. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Commun (Lond) 2024;44:521–553. doi: 10.1002/cac2.12539.</cite> [<a href="https://doi.org/10.1002/cac2.12539" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11110955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38551889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Commun%20(Lond)&amp;title=Immunologic%20tumor%20microenvironment%20modulators%20for%20turning%20cold%20tumors%20hot&amp;author=G%20Khosravi&amp;author=S%20Mostafavi&amp;author=S%20Bastan&amp;author=N%20Ebrahimi&amp;author=RS%20Gharibvand&amp;volume=44&amp;publication_year=2024&amp;pages=521-553&amp;pmid=38551889&amp;doi=10.1002/cac2.12539&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b5-ijo-67-04-05787">
<span class="label">5.</span><cite>Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753. doi: 10.1016/j.pharmthera.2020.107753.</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2020.107753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8084948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33259885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Ther&amp;title=Tumor%20microenvironment%20as%20a%20therapeutic%20target%20in%20cancer&amp;author=Y%20Xiao&amp;author=D%20Yu&amp;volume=221&amp;publication_year=2021&amp;pages=107753&amp;pmid=33259885&amp;doi=10.1016/j.pharmthera.2020.107753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b6-ijo-67-04-05787">
<span class="label">6.</span><cite>Wilson JJ, Burgess R, Mao Y, Luo S, Tang H, Jones VS, Weisheng B, Huang RY, Chen X, Huang RP. Antibody arrays in biomarker discovery. Adv Clin Chem. 2015;69:255–324. doi: 10.1016/bs.acc.2015.01.002.</cite> [<a href="https://doi.org/10.1016/bs.acc.2015.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25934364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Clin%20Chem&amp;title=Antibody%20arrays%20in%20biomarker%20discovery&amp;author=JJ%20Wilson&amp;author=R%20Burgess&amp;author=Y%20Mao&amp;author=S%20Luo&amp;author=H%20Tang&amp;volume=69&amp;publication_year=2015&amp;pages=255-324&amp;pmid=25934364&amp;doi=10.1016/bs.acc.2015.01.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b7-ijo-67-04-05787">
<span class="label">7.</span><cite>Goetz JG, Minguet S, Navarro-Lerida I, Lacoste J, Ang LH, Fiering S, Reproducibility Project  Cancer Biology: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell. 2011;146:148–163. doi: 10.1016/j.cell.2011.05.040.</cite> [<a href="https://doi.org/10.1016/j.cell.2011.05.040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3244213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21729786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Cancer%20Biology:%20Biomechanical%20remodeling%20of%20the%20microenvironment%20by%20stromal%20caveolin-1%20favors%20tumor%20invasion%20and%20metastasis&amp;author=JG%20Goetz&amp;author=S%20Minguet&amp;author=I%20Navarro-Lerida&amp;author=J%20Lacoste&amp;author=LH%20Ang&amp;volume=146&amp;publication_year=2011&amp;pages=148-163&amp;pmid=21729786&amp;doi=10.1016/j.cell.2011.05.040&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b8-ijo-67-04-05787">
<span class="label">8.</span><cite>Chen W, Ho C, Chang Y, Chen HY, Lin CA, Ling TY, Yu SL, Yuan SS, Chen YJ, Lin CY, et al.  Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nat Commun. 2014;5:3472. doi: 10.1038/ncomms4472.</cite> [<a href="https://doi.org/10.1038/ncomms4472" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24668028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Cancer-associated%20fibroblasts%20regulate%20the%20plasticity%20of%20lung%20cancer%20stemness%20via%20paracrine%20signalling&amp;author=W%20Chen&amp;author=C%20Ho&amp;author=Y%20Chang&amp;author=HY%20Chen&amp;author=CA%20Lin&amp;volume=5&amp;publication_year=2014&amp;pages=3472&amp;pmid=24668028&amp;doi=10.1038/ncomms4472&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b9-ijo-67-04-05787">
<span class="label">9.</span><cite>Bellei B, Caputo S, Migliano E, Lopez G, Marcaccini V, Cota C, Picardo M. Simultaneous targeting tumor cells and cancer-associated fibroblasts with a paclitaxel-hyaluronan bioconjugate: In vitro evaluation in non-melanoma skin cancer. Biomedicines. 2021;9:597. doi: 10.3390/biomedicines9060597.</cite> [<a href="https://doi.org/10.3390/biomedicines9060597" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8225214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34073987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicines&amp;title=Simultaneous%20targeting%20tumor%20cells%20and%20cancer-associated%20fibroblasts%20with%20a%20paclitaxel-hyaluronan%20bioconjugate:%20In%20vitro%20evaluation%20in%20non-melanoma%20skin%20cancer&amp;author=B%20Bellei&amp;author=S%20Caputo&amp;author=E%20Migliano&amp;author=G%20Lopez&amp;author=V%20Marcaccini&amp;volume=9&amp;publication_year=2021&amp;pages=597&amp;pmid=34073987&amp;doi=10.3390/biomedicines9060597&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b10-ijo-67-04-05787">
<span class="label">10.</span><cite>Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C, et al.  Fibroblast Heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33:463–479. doi: 10.1016/j.ccell.2018.01.011.</cite> [<a href="https://doi.org/10.1016/j.ccell.2018.01.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29455927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Fibroblast%20Heterogeneity%20and%20immunosuppressive%20environment%20in%20human%20breast%20cancer&amp;author=A%20Costa&amp;author=Y%20Kieffer&amp;author=A%20Scholer-Dahirel&amp;author=F%20Pelon&amp;author=B%20Bourachot&amp;volume=33&amp;publication_year=2018&amp;pages=463-479&amp;pmid=29455927&amp;doi=10.1016/j.ccell.2018.01.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b11-ijo-67-04-05787">
<span class="label">11.</span><cite>Hu H, Piotrowska Z, Hare PJ, Chen H, Mulvey HE, Mayfield A, Noeen S, Kattermann K, Greenberg M, Williams A, et al.  Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. Cancer Cell. 2021;39:1531–1547. doi: 10.1016/j.ccell.2021.09.003.</cite> [<a href="https://doi.org/10.1016/j.ccell.2021.09.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8578451/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34624218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Three%20subtypes%20of%20lung%20cancer%20fibroblasts%20define%20distinct%20therapeutic%20paradigms&amp;author=H%20Hu&amp;author=Z%20Piotrowska&amp;author=PJ%20Hare&amp;author=H%20Chen&amp;author=HE%20Mulvey&amp;volume=39&amp;publication_year=2021&amp;pages=1531-1547&amp;pmid=34624218&amp;doi=10.1016/j.ccell.2021.09.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b12-ijo-67-04-05787">
<span class="label">12.</span><cite>Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X, et al.  Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell. 2021;39:866–882. doi: 10.1016/j.ccell.2021.03.012.</cite> [<a href="https://doi.org/10.1016/j.ccell.2021.03.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8241235/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33930309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Promotion%20of%20cholangiocarcinoma%20growth%20by%20diverse%20cancer-associated%20fibroblast%20subpopulations&amp;author=S%20Affo&amp;author=A%20Nair&amp;author=F%20Brundu&amp;author=A%20Ravichandra&amp;author=S%20Bhattacharjee&amp;volume=39&amp;publication_year=2021&amp;pages=866-882&amp;pmid=33930309&amp;doi=10.1016/j.ccell.2021.03.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b13-ijo-67-04-05787">
<span class="label">13.</span><cite>LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R. Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013;19:1047–1053. doi: 10.1038/nm.3218.</cite> [<a href="https://doi.org/10.1038/nm.3218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4067127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23817022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Origin%20and%20function%20of%20myofibroblasts%20in%20kidney%20fibrosis&amp;author=VS%20LeBleu&amp;author=G%20Taduri&amp;author=J%20O'Connell&amp;author=Y%20Teng&amp;author=VG%20Cooke&amp;volume=19&amp;publication_year=2013&amp;pages=1047-1053&amp;pmid=23817022&amp;doi=10.1038/nm.3218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b14-ijo-67-04-05787">
<span class="label">14.</span><cite>Jotzu C, Alt E, Welte G, Li J, Hennessy BT, Devarajan E, Krishnappa S, Pinilla S, Droll L, Song YH. Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors. Cell Oncol (Dordr) 2011;34:55–67. doi: 10.1007/s13402-011-0012-1.</cite> [<a href="https://doi.org/10.1007/s13402-011-0012-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21327615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Oncol%20(Dordr)&amp;title=Adipose%20tissue%20derived%20stem%20cells%20differentiate%20into%20carcinoma-associated%20fibroblast-like%20cells%20under%20the%20influence%20of%20tumor%20derived%20factors&amp;author=C%20Jotzu&amp;author=E%20Alt&amp;author=G%20Welte&amp;author=J%20Li&amp;author=BT%20Hennessy&amp;volume=34&amp;publication_year=2011&amp;pages=55-67&amp;pmid=21327615&amp;doi=10.1007/s13402-011-0012-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b15-ijo-67-04-05787">
<span class="label">15.</span><cite>Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 2001;264:169–184. doi: 10.1006/excr.2000.5133.</cite> [<a href="https://doi.org/10.1006/excr.2000.5133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11237532/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Cell%20Res&amp;title=Heterotypic%20signaling%20between%20epithelial%20tumor%20cells%20and%20fibroblasts%20in%20carcinoma%20formation&amp;author=B%20Elenbaas&amp;author=RA%20Weinberg&amp;volume=264&amp;publication_year=2001&amp;pages=169-184&amp;pmid=11237532&amp;doi=10.1006/excr.2000.5133&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b16-ijo-67-04-05787">
<span class="label">16.</span><cite>Fang T, Lv H, Lv G, Li T, Wang C, Han Q, Yu L, Su B, Guo L, Huang S, et al.  Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9:191. doi: 10.1038/s41467-017-02583-0.</cite> [<a href="https://doi.org/10.1038/s41467-017-02583-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5768693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29335551/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Tumor-derived%20exosomal%20miR-1247-3p%20induces%20cancer-associated%20fibroblast%20activation%20to%20foster%20lung%20metastasis%20of%20liver%20cancer&amp;author=T%20Fang&amp;author=H%20Lv&amp;author=G%20Lv&amp;author=T%20Li&amp;author=C%20Wang&amp;volume=9&amp;publication_year=2018&amp;pages=191&amp;pmid=29335551&amp;doi=10.1038/s41467-017-02583-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b17-ijo-67-04-05787">
<span class="label">17.</span><cite>Comito G, Giannoni E, Segura CP, Barcellos-de-Souza P, Raspollini MR, Baroni G, Lanciotti M, Serni S, Chiarugi P. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene. 2014;33:2423–2431. doi: 10.1038/onc.2013.191.</cite> [<a href="https://doi.org/10.1038/onc.2013.191" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23728338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Cancer-associated%20fibroblasts%20and%20M2-polarized%20macrophages%20synergize%20during%20prostate%20carcinoma%20progression&amp;author=G%20Comito&amp;author=E%20Giannoni&amp;author=CP%20Segura&amp;author=P%20Barcellos-de-Souza&amp;author=MR%20Raspollini&amp;volume=33&amp;publication_year=2014&amp;pages=2423-2431&amp;pmid=23728338&amp;doi=10.1038/onc.2013.191&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b18-ijo-67-04-05787">
<span class="label">18.</span><cite>Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP, Tattersall IW, et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25:735–747. doi: 10.1016/j.ccr.2014.04.021.</cite> [<a href="https://doi.org/10.1016/j.ccr.2014.04.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4096698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24856585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Stromal%20elements%20act%20to%20restrain,%20rather%20than%20support,%20pancreatic%20ductal%20adenocarcinoma&amp;author=AD%20Rhim&amp;author=PE%20Oberstein&amp;author=DH%20Thomas&amp;author=ET%20Mirek&amp;author=CF%20Palermo&amp;volume=25&amp;publication_year=2014&amp;pages=735-747&amp;pmid=24856585&amp;doi=10.1016/j.ccr.2014.04.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b19-ijo-67-04-05787">
<span class="label">19.</span><cite>Ozdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719–734. doi: 10.1016/j.ccr.2014.04.005.</cite> [<a href="https://doi.org/10.1016/j.ccr.2014.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4180632/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24856586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Depletion%20of%20carcinoma-associated%20fibroblasts%20and%20fibrosis%20induces%20immunosuppression%20and%20accelerates%20pancreas%20cancer%20with%20reduced%20survival&amp;author=BC%20Ozdemir&amp;author=T%20Pentcheva-Hoang&amp;author=JL%20Carstens&amp;author=X%20Zheng&amp;author=CC%20Wu&amp;volume=25&amp;publication_year=2014&amp;pages=719-734&amp;pmid=24856586&amp;doi=10.1016/j.ccr.2014.04.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b20-ijo-67-04-05787">
<span class="label">20.</span><cite>Vinogradov S, Warren G, Wei X. Macrophages associated with tumors as potential targets and therapeutic intermediates. Nanomedicine(Lond) 2014;9:695–707. doi: 10.2217/nnm.14.13.</cite> [<a href="https://doi.org/10.2217/nnm.14.13" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4149280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24827844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine(Lond)&amp;title=Macrophages%20associated%20with%20tumors%20as%20potential%20targets%20and%20therapeutic%20intermediates&amp;author=S%20Vinogradov&amp;author=G%20Warren&amp;author=X%20Wei&amp;volume=9&amp;publication_year=2014&amp;pages=695-707&amp;pmid=24827844&amp;doi=10.2217/nnm.14.13&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b21-ijo-67-04-05787">
<span class="label">21.</span><cite>Larionova I, Cherdyntseva N, Liu T, Patysheva M, Rakina M, Kzhyshkowska J. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology. 2019;8:1596004. doi: 10.1080/2162402X.2019.1596004.</cite> [<a href="https://doi.org/10.1080/2162402X.2019.1596004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6527283/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31143517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncoimmunology&amp;title=Interaction%20of%20tumor-associated%20macrophages%20and%20cancer%20chemotherapy&amp;author=I%20Larionova&amp;author=N%20Cherdyntseva&amp;author=T%20Liu&amp;author=M%20Patysheva&amp;author=M%20Rakina&amp;volume=8&amp;publication_year=2019&amp;pages=1596004&amp;pmid=31143517&amp;doi=10.1080/2162402X.2019.1596004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b22-ijo-67-04-05787">
<span class="label">22.</span><cite>Rodriguez-Garcia A, Lynn RC, Poussin M, Eiva MA, Shaw LC, O'Connor RS, Minutolo NG, Casado-Medrano V, Lopez G, Matsuyama T, Powell DJ., Jr CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy. Nat Commun. 2021;12:877. doi: 10.1038/s41467-021-20893-2.</cite> [<a href="https://doi.org/10.1038/s41467-021-20893-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7873057/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33563975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=CAR-T%20cell-mediated%20depletion%20of%20immunosuppressive%20tumor-associated%20macrophages%20promotes%20endogenous%20antitumor%20immunity%20and%20augments%20adoptive%20immunotherapy&amp;author=A%20Rodriguez-Garcia&amp;author=RC%20Lynn&amp;author=M%20Poussin&amp;author=MA%20Eiva&amp;author=LC%20Shaw&amp;volume=12&amp;publication_year=2021&amp;pages=877&amp;pmid=33563975&amp;doi=10.1038/s41467-021-20893-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b23-ijo-67-04-05787">
<span class="label">23.</span><cite>Takeya M, Komohara Y. Role of tumor-associated macrophages in human malignancies: Friend or foe? Pathol Int. 2016;66:491–505. doi: 10.1111/pin.12440.</cite> [<a href="https://doi.org/10.1111/pin.12440" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27444136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathol%20Int&amp;title=Role%20of%20tumor-associated%20macrophages%20in%20human%20malignancies:%20Friend%20or%20foe?&amp;author=M%20Takeya&amp;author=Y%20Komohara&amp;volume=66&amp;publication_year=2016&amp;pages=491-505&amp;pmid=27444136&amp;doi=10.1111/pin.12440&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b24-ijo-67-04-05787">
<span class="label">24.</span><cite>Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat Immunol. 2010;11:889–896. doi: 10.1038/ni.1937.</cite> [<a href="https://doi.org/10.1038/ni.1937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20856220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Immunol&amp;title=Macrophage%20plasticity%20and%20interaction%20with%20lymphocyte%20subsets:%20Cancer%20as%20a%20paradigm&amp;author=SK%20Biswas&amp;author=A%20Mantovani&amp;volume=11&amp;publication_year=2010&amp;pages=889-896&amp;pmid=20856220&amp;doi=10.1038/ni.1937&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b25-ijo-67-04-05787">
<span class="label">25.</span><cite>van Dalen FJ, van Stevendaal MHME, Fennemann FL, Verdoes M, Ilina O. Molecular repolarisation of tumour-associated macrophages. Molecules. 2018;24:9. doi: 10.3390/molecules24010009.</cite> [<a href="https://doi.org/10.3390/molecules24010009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6337345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30577495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Molecular%20repolarisation%20of%20tumour-associated%20macrophages&amp;author=FJ%20van%20Dalen&amp;author=MHME%20van%20Stevendaal&amp;author=FL%20Fennemann&amp;author=M%20Verdoes&amp;author=O%20Ilina&amp;volume=24&amp;publication_year=2018&amp;pages=9&amp;pmid=30577495&amp;doi=10.3390/molecules24010009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b26-ijo-67-04-05787">
<span class="label">26.</span><cite>Cheng H, Wang Z, Fu L, Xu T. Macrophage polarization in the development and progression of ovarian cancers: An overview. Front Oncol. 2019;9:421. doi: 10.3389/fonc.2019.00421.</cite> [<a href="https://doi.org/10.3389/fonc.2019.00421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6540821/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31192126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Macrophage%20polarization%20in%20the%20development%20and%20progression%20of%20ovarian%20cancers:%20An%20overview&amp;author=H%20Cheng&amp;author=Z%20Wang&amp;author=L%20Fu&amp;author=T%20Xu&amp;volume=9&amp;publication_year=2019&amp;pages=421&amp;pmid=31192126&amp;doi=10.3389/fonc.2019.00421&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b27-ijo-67-04-05787">
<span class="label">27.</span><cite>Li S, Yu J, Huber A, Kryczek I, Wang Z, Jiang L, Li X, Du W, Li G, Wei S, et al.  Metabolism drives macrophage heterogeneity in the tumor microenvironment. Cell Rep. 2022;39:110609. doi: 10.1016/j.celrep.2022.110609.</cite> [<a href="https://doi.org/10.1016/j.celrep.2022.110609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9052943/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35385733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Rep&amp;title=Metabolism%20drives%20macrophage%20heterogeneity%20in%20the%20tumor%20microenvironment&amp;author=S%20Li&amp;author=J%20Yu&amp;author=A%20Huber&amp;author=I%20Kryczek&amp;author=Z%20Wang&amp;volume=39&amp;publication_year=2022&amp;pages=110609&amp;pmid=35385733&amp;doi=10.1016/j.celrep.2022.110609&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b28-ijo-67-04-05787">
<span class="label">28.</span><cite>Wang Y, Tiruthani K, Li S, Hu M, Zhong G, Tang Y, Roy S, Zhang L, Tan J, Liao C, Liu R. mRNA delivery of a bispecific single-domain antibody to polarize tumor-associated macrophages and synergize immunotherapy against liver malignancies. Adv Mater. 2021;33:e2007603. doi: 10.1002/adma.202007603.</cite> [<a href="https://doi.org/10.1002/adma.202007603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8240965/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33945178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Mater&amp;title=mRNA%20delivery%20of%20a%20bispecific%20single-domain%20antibody%20to%20polarize%20tumor-associated%20macrophages%20and%20synergize%20immunotherapy%20against%20liver%20malignancies&amp;author=Y%20Wang&amp;author=K%20Tiruthani&amp;author=S%20Li&amp;author=M%20Hu&amp;author=G%20Zhong&amp;volume=33&amp;publication_year=2021&amp;pages=e2007603&amp;pmid=33945178&amp;doi=10.1002/adma.202007603&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b29-ijo-67-04-05787">
<span class="label">29.</span><cite>Su S, Liu Q, Chen J, Chen J, Chen F, He C, Huang D, Wu W, Lin L, Huang W, et al.  A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014;25:605–620. doi: 10.1016/j.ccr.2014.03.021.</cite> [<a href="https://doi.org/10.1016/j.ccr.2014.03.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24823638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=A%20positive%20feedback%20loop%20between%20mesenchymal-like%20cancer%20cells%20and%20macrophages%20is%20essential%20to%20breast%20cancer%20metastasis&amp;author=S%20Su&amp;author=Q%20Liu&amp;author=J%20Chen&amp;author=J%20Chen&amp;author=F%20Chen&amp;volume=25&amp;publication_year=2014&amp;pages=605-620&amp;pmid=24823638&amp;doi=10.1016/j.ccr.2014.03.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b30-ijo-67-04-05787">
<span class="label">30.</span><cite>Vickman RE, Broman MM, Lanman NA, Franco OE, Sudyanti PAG, Ni Y, Ji Y, Helfand BT, Petkewicz J, Paterakos MC, et al.  Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment. Prostate. 2020;80:173–185. doi: 10.1002/pros.23929.</cite> [<a href="https://doi.org/10.1002/pros.23929" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12004274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31763714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Heterogeneity%20of%20human%20prostate%20carcinoma-associated%20fibroblasts%20implicates%20a%20role%20for%20subpopulations%20in%20myeloid%20cell%20recruitment&amp;author=RE%20Vickman&amp;author=MM%20Broman&amp;author=NA%20Lanman&amp;author=OE%20Franco&amp;author=PAG%20Sudyanti&amp;volume=80&amp;publication_year=2020&amp;pages=173-185&amp;pmid=31763714&amp;doi=10.1002/pros.23929&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b31-ijo-67-04-05787">
<span class="label">31.</span><cite>Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, Levchenko T, Frederick MJ, Borg A, Micke P, Egevad L, Ostman A. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci USA. 2009;106:3414–3419. doi: 10.1073/pnas.0813144106.</cite> [<a href="https://doi.org/10.1073/pnas.0813144106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2651265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19218429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=CXCL14%20is%20an%20autocrine%20growth%20factor%20for%20fibroblasts%20and%20acts%20as%20a%20multi-modal%20stimulator%20of%20prostate%20tumor%20growth&amp;author=M%20Augsten&amp;author=C%20Hagglof&amp;author=E%20Olsson&amp;author=C%20Stolz&amp;author=P%20Tsagozis&amp;volume=106&amp;publication_year=2009&amp;pages=3414-3419&amp;pmid=19218429&amp;doi=10.1073/pnas.0813144106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b32-ijo-67-04-05787">
<span class="label">32.</span><cite>Seckinger A, Delgado JA, Moser S, Moreno L, Neuber B, Grab A, Lipp S, Merino J, Prosper F, Emde M, et al.  Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment. Cancer Cell. 2017;31:396–410. doi: 10.1016/j.ccell.2017.02.002.</cite> [<a href="https://doi.org/10.1016/j.ccell.2017.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28262554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Target%20expression,%20generation,%20preclinical%20activity,%20and%20pharmacokinetics%20of%20the%20BCMA-T%20cell%20bispecific%20antibody%20EM801%20for%20multiple%20myeloma%20treatment&amp;author=A%20Seckinger&amp;author=JA%20Delgado&amp;author=S%20Moser&amp;author=L%20Moreno&amp;author=B%20Neuber&amp;volume=31&amp;publication_year=2017&amp;pages=396-410&amp;pmid=28262554&amp;doi=10.1016/j.ccell.2017.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b33-ijo-67-04-05787">
<span class="label">33.</span><cite>Zhang X, Xu J, Zhu H, Wang Y, Wang L, Fan L, Wu YJ, Li JY, Xu W. Negative prognostic impact of low absolute CD4(+) T cell counts in peripheral blood in mantle cell lymphoma. Cancer Sci. 2016;107:1471–1476. doi: 10.1111/cas.13020.</cite> [<a href="https://doi.org/10.1111/cas.13020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5084668/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27465799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci&amp;title=Negative%20prognostic%20impact%20of%20low%20absolute%20CD4(+)%20T%20cell%20counts%20in%20peripheral%20blood%20in%20mantle%20cell%20lymphoma&amp;author=X%20Zhang&amp;author=J%20Xu&amp;author=H%20Zhu&amp;author=Y%20Wang&amp;author=L%20Wang&amp;volume=107&amp;publication_year=2016&amp;pages=1471-1476&amp;pmid=27465799&amp;doi=10.1111/cas.13020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b34-ijo-67-04-05787">
<span class="label">34.</span><cite>Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451–455. doi: 10.1038/nature12726.</cite> [<a href="https://doi.org/10.1038/nature12726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3869884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24226773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Metabolites%20produced%20by%20commensal%20bacteria%20promote%20peripheral%20regulatory%20T-cell%20generation&amp;author=N%20Arpaia&amp;author=C%20Campbell&amp;author=X%20Fan&amp;author=S%20Dikiy&amp;author=J%20van%20der%20Veeken&amp;volume=504&amp;publication_year=2013&amp;pages=451-455&amp;pmid=24226773&amp;doi=10.1038/nature12726&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b35-ijo-67-04-05787">
<span class="label">35.</span><cite>Chen X, Du Y, Hu Q, Huang Z. Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4. Pathol Res Pract. 2017;213:245–249. doi: 10.1016/j.prp.2016.12.008.</cite> [<a href="https://doi.org/10.1016/j.prp.2016.12.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28214198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathol%20Res%20Pract&amp;title=Tumor-derived%20CD4+CD25+regulatory%20T%20cells%20inhibit%20dendritic%20cells%20function%20by%20CTLA-4&amp;author=X%20Chen&amp;author=Y%20Du&amp;author=Q%20Hu&amp;author=Z%20Huang&amp;volume=213&amp;publication_year=2017&amp;pages=245-249&amp;pmid=28214198&amp;doi=10.1016/j.prp.2016.12.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b36-ijo-67-04-05787">
<span class="label">36.</span><cite>Burkholder B, Huang R, Burgess R, Luo S, Jones VS, Zhang W, Lv ZQ, Gao CY, Wang BL, Zhang YM, Huang RP. Tumor-induced perturbations of cytokines and immune cell networks. Biochim Biophys Acta. 2014;1845:182–201. doi: 10.1016/j.bbcan.2014.01.004.</cite> [<a href="https://doi.org/10.1016/j.bbcan.2014.01.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24440852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochim%20Biophys%20Acta&amp;title=Tumor-induced%20perturbations%20of%20cytokines%20and%20immune%20cell%20networks&amp;author=B%20Burkholder&amp;author=R%20Huang&amp;author=R%20Burgess&amp;author=S%20Luo&amp;author=VS%20Jones&amp;volume=1845&amp;publication_year=2014&amp;pages=182-201&amp;pmid=24440852&amp;doi=10.1016/j.bbcan.2014.01.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b37-ijo-67-04-05787">
<span class="label">37.</span><cite>Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013;13:739–752. doi: 10.1038/nrc3581.</cite> [<a href="https://doi.org/10.1038/nrc3581" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4358792/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24060865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=History%20of%20myeloid-derived%20suppressor%20cells&amp;author=JE%20Talmadge&amp;author=DI%20Gabrilovich&amp;volume=13&amp;publication_year=2013&amp;pages=739-752&amp;pmid=24060865&amp;doi=10.1038/nrc3581&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b38-ijo-67-04-05787">
<span class="label">38.</span><cite>Hegde S, Leader AM, Merad M. MDSC: Markers, development, states, and unaddressed complexity. Immunity. 2021;54:875–884. doi: 10.1016/j.immuni.2021.04.004.</cite> [<a href="https://doi.org/10.1016/j.immuni.2021.04.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8709560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33979585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=MDSC:%20Markers,%20development,%20states,%20and%20unaddressed%20complexity&amp;author=S%20Hegde&amp;author=AM%20Leader&amp;author=M%20Merad&amp;volume=54&amp;publication_year=2021&amp;pages=875-884&amp;pmid=33979585&amp;doi=10.1016/j.immuni.2021.04.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b39-ijo-67-04-05787">
<span class="label">39.</span><cite>Wang L, Si W, Yu X, Piffko A, Dou X, Ding X, Bugno J, Yang K, Wen C, Zhang L, et al.  Epitranscriptional regulation of TGF-beta pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance. J Clin Invest. 2023;133:e172919. doi: 10.1172/JCI172919.</cite> [<a href="https://doi.org/10.1172/JCI172919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10721150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38099498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Invest&amp;title=Epitranscriptional%20regulation%20of%20TGF-beta%20pseudoreceptor%20BAMBI%20by%20m6A/YTHDF2%20drives%20extrinsic%20radioresistance&amp;author=L%20Wang&amp;author=W%20Si&amp;author=X%20Yu&amp;author=A%20Piffko&amp;author=X%20Dou&amp;volume=133&amp;publication_year=2023&amp;pages=e172919&amp;pmid=38099498&amp;doi=10.1172/JCI172919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b40-ijo-67-04-05787">
<span class="label">40.</span><cite>Zhou J, Xu H, Li X, Liu H, Sun Z, Li J, Tang Y, Gao H, Zhao K, Ding C, Gao X. Targeting tumorous Circ-E-Cadherinencoded C-E-Cad inhibits the recruitment and function of breast cancer-associated myeloid-derived suppressor cells. Pharmacol Res. 2024;204:107204. doi: 10.1016/j.phrs.2024.107204.</cite> [<a href="https://doi.org/10.1016/j.phrs.2024.107204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38704109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Res&amp;title=Targeting%20tumorous%20Circ-E-Cadherinencoded%20C-E-Cad%20inhibits%20the%20recruitment%20and%20function%20of%20breast%20cancer-associated%20myeloid-derived%20suppressor%20cells&amp;author=J%20Zhou&amp;author=H%20Xu&amp;author=X%20Li&amp;author=H%20Liu&amp;author=Z%20Sun&amp;volume=204&amp;publication_year=2024&amp;pages=107204&amp;pmid=38704109&amp;doi=10.1016/j.phrs.2024.107204&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b41-ijo-67-04-05787">
<span class="label">41.</span><cite>Gregory AD, Houghton AM. Tumor-associated neutrophils: New targets for cancer therapy. Cancer Res. 2011;71:2411–2416. doi: 10.1158/0008-5472.CAN-10-2583.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-10-2583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21427354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Tumor-associated%20neutrophils:%20New%20targets%20for%20cancer%20therapy&amp;author=AD%20Gregory&amp;author=AM%20Houghton&amp;volume=71&amp;publication_year=2011&amp;pages=2411-2416&amp;pmid=21427354&amp;doi=10.1158/0008-5472.CAN-10-2583&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b42-ijo-67-04-05787">
<span class="label">42.</span><cite>Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: Neutral no more. Nat Rev Cancer. 2016;16:431–446. doi: 10.1038/nrc.2016.52.</cite> [<a href="https://doi.org/10.1038/nrc.2016.52" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27282249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Neutrophils%20in%20cancer:%20Neutral%20no%20more&amp;author=SB%20Coffelt&amp;author=MD%20Wellenstein&amp;author=KE%20de%20Visser&amp;volume=16&amp;publication_year=2016&amp;pages=431-446&amp;pmid=27282249&amp;doi=10.1038/nrc.2016.52&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b43-ijo-67-04-05787">
<span class="label">43.</span><cite>Shaul ME, Fridlender ZG. Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 2019;16:601–620. doi: 10.1038/s41571-019-0222-4.</cite> [<a href="https://doi.org/10.1038/s41571-019-0222-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31160735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Tumour-associated%20neutrophils%20in%20patients%20with%20cancer&amp;author=ME%20Shaul&amp;author=ZG%20Fridlender&amp;volume=16&amp;publication_year=2019&amp;pages=601-620&amp;pmid=31160735&amp;doi=10.1038/s41571-019-0222-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b44-ijo-67-04-05787">
<span class="label">44.</span><cite>Melstrom LG, Salazar MD, Diamond DJ. The pancreatic cancer microenvironment: A true double agent. J Surg Oncol. 2017;116:7–15. doi: 10.1002/jso.24643.</cite> [<a href="https://doi.org/10.1002/jso.24643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5989710/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28605029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Surg%20Oncol&amp;title=The%20pancreatic%20cancer%20microenvironment:%20A%20true%20double%20agent&amp;author=LG%20Melstrom&amp;author=MD%20Salazar&amp;author=DJ%20Diamond&amp;volume=116&amp;publication_year=2017&amp;pages=7-15&amp;pmid=28605029&amp;doi=10.1002/jso.24643&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b45-ijo-67-04-05787">
<span class="label">45.</span><cite>Kalafati L, Kourtzelis I, Schulte-Schrepping J, Li X, Hatzioannou A, Grinenko T, Hagag E, Sinha A, Has C, Dietz S, et al.  Innate immune training of granulopoiesis promotes anti-tumor activity. Cell. 2020;183:771–785. doi: 10.1016/j.cell.2020.09.058.</cite> [<a href="https://doi.org/10.1016/j.cell.2020.09.058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7599076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33125892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Innate%20immune%20training%20of%20granulopoiesis%20promotes%20anti-tumor%20activity&amp;author=L%20Kalafati&amp;author=I%20Kourtzelis&amp;author=J%20Schulte-Schrepping&amp;author=X%20Li&amp;author=A%20Hatzioannou&amp;volume=183&amp;publication_year=2020&amp;pages=771-785&amp;pmid=33125892&amp;doi=10.1016/j.cell.2020.09.058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b46-ijo-67-04-05787">
<span class="label">46.</span><cite>Cui C, Chakraborty K, Tang XA, Zhou G, Schoenfelt KQ, Becker KM, Hoffman A, Chang YF, Blank A, Reardon CA, et al.  Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell. 2021;184:3163–3177. doi: 10.1016/j.cell.2021.04.016.</cite> [<a href="https://doi.org/10.1016/j.cell.2021.04.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10712736/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33964209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Neutrophil%20elastase%20selectively%20kills%20cancer%20cells%20and%20attenuates%20tumorigenesis&amp;author=C%20Cui&amp;author=K%20Chakraborty&amp;author=XA%20Tang&amp;author=G%20Zhou&amp;author=KQ%20Schoenfelt&amp;volume=184&amp;publication_year=2021&amp;pages=3163-3177&amp;pmid=33964209&amp;doi=10.1016/j.cell.2021.04.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b47-ijo-67-04-05787">
<span class="label">47.</span><cite>Xiao Y, Cong M, Li J, He D, Wu Q, Tian P, Wang Y, Yang S, Liang C, Liang Y, et al.  Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. Cancer Cell. 2021;39:423–437. doi: 10.1016/j.ccell.2020.12.012.</cite> [<a href="https://doi.org/10.1016/j.ccell.2020.12.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33450198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Cathepsin%20C%20promotes%20breast%20cancer%20lung%20metastasis%20by%20modulating%20neutrophil%20infiltration%20and%20neutrophil%20extracellular%20trap%20formation&amp;author=Y%20Xiao&amp;author=M%20Cong&amp;author=J%20Li&amp;author=D%20He&amp;author=Q%20Wu&amp;volume=39&amp;publication_year=2021&amp;pages=423-437&amp;pmid=33450198&amp;doi=10.1016/j.ccell.2020.12.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b48-ijo-67-04-05787">
<span class="label">48.</span><cite>Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020;20:485–503. doi: 10.1038/s41568-020-0281-y.</cite> [<a href="https://doi.org/10.1038/s41568-020-0281-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32694624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Neutrophil%20diversity%20and%20plasticity%20in%20tumour%20progression%20and%20therapy&amp;author=S%20Jaillon&amp;author=A%20Ponzetta&amp;author=D%20Di%20Mitri&amp;author=A%20Santoni&amp;author=R%20Bonecchi&amp;volume=20&amp;publication_year=2020&amp;pages=485-503&amp;pmid=32694624&amp;doi=10.1038/s41568-020-0281-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b49-ijo-67-04-05787">
<span class="label">49.</span><cite>Xu X, Ye L, Zhang Q, Shen H, Li S, Zhang X, Ye M, Liang T. Group-2 innate lymphoid cells promote HCC progression through CXCL2-neutrophil-induced immunosuppression. Hepatology. 2021;74:2526–2543. doi: 10.1002/hep.31855.</cite> [<a href="https://doi.org/10.1002/hep.31855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8597094/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33829508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Group-2%20innate%20lymphoid%20cells%20promote%20HCC%20progression%20through%20CXCL2-neutrophil-induced%20immunosuppression&amp;author=X%20Xu&amp;author=L%20Ye&amp;author=Q%20Zhang&amp;author=H%20Shen&amp;author=S%20Li&amp;volume=74&amp;publication_year=2021&amp;pages=2526-2543&amp;pmid=33829508&amp;doi=10.1002/hep.31855&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b50-ijo-67-04-05787">
<span class="label">50.</span><cite>Kuang Z, Wilson JJ, Luo S, Zhu S, Huang R. Deciphering asthma biomarkers with protein profiling technology. Int J Inflamm. 2015;2015:630637. doi: 10.1155/2015/630637.</cite> [<a href="https://doi.org/10.1155/2015/630637" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4543788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26346739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Inflamm&amp;title=Deciphering%20asthma%20biomarkers%20with%20protein%20profiling%20technology&amp;author=Z%20Kuang&amp;author=JJ%20Wilson&amp;author=S%20Luo&amp;author=S%20Zhu&amp;author=R%20Huang&amp;volume=2015&amp;publication_year=2015&amp;pages=630637&amp;pmid=26346739&amp;doi=10.1155/2015/630637&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b51-ijo-67-04-05787">
<span class="label">51.</span><cite>Dicarlo M, Bianchi N, Ferretti C, Orciani M, Di Primio R, Mattioli-Belmonte M. Evidence supporting a paracrine effect of IGF-1/VEGF on human mesenchymal stromal cell commitment. Cells Tissues Organs. 2016;201:333–341. doi: 10.1159/000445346.</cite> [<a href="https://doi.org/10.1159/000445346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27179123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells%20Tissues%20Organs&amp;title=Evidence%20supporting%20a%20paracrine%20effect%20of%20IGF-1/VEGF%20on%20human%20mesenchymal%20stromal%20cell%20commitment&amp;author=M%20Dicarlo&amp;author=N%20Bianchi&amp;author=C%20Ferretti&amp;author=M%20Orciani&amp;author=R%20Di%20Primio&amp;volume=201&amp;publication_year=2016&amp;pages=333-341&amp;pmid=27179123&amp;doi=10.1159/000445346&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b52-ijo-67-04-05787">
<span class="label">52.</span><cite>Goel HL, Mercurio AM. VEGF targets the tumour cell. Nat Rev Cancer. 2013;13:871–882. doi: 10.1038/nrc3627.</cite> [<a href="https://doi.org/10.1038/nrc3627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4011842/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24263190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=VEGF%20targets%20the%20tumour%20cell&amp;author=HL%20Goel&amp;author=AM%20Mercurio&amp;volume=13&amp;publication_year=2013&amp;pages=871-882&amp;pmid=24263190&amp;doi=10.1038/nrc3627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b53-ijo-67-04-05787">
<span class="label">53.</span><cite>Iams WT, Lovly CM. Molecular pathways: Clinical applications and future direction of insulin-like growth factor-1 receptor pathway blockade. Clin Cancer Res. 2015;21:4270–4277. doi: 10.1158/1078-0432.CCR-14-2518.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-14-2518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4593065/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26429980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Molecular%20pathways:%20Clinical%20applications%20and%20future%20direction%20of%20insulin-like%20growth%20factor-1%20receptor%20pathway%20blockade&amp;author=WT%20Iams&amp;author=CM%20Lovly&amp;volume=21&amp;publication_year=2015&amp;pages=4270-4277&amp;pmid=26429980&amp;doi=10.1158/1078-0432.CCR-14-2518&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b54-ijo-67-04-05787">
<span class="label">54.</span><cite>Sanchez-Lopez E, Flashner-Abramson E, Shalapour S, Zhong Z, Taniguchi K, Levitzki A, Karin M. Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling. Oncogene. 2016;35:2634–2644. doi: 10.1038/onc.2015.326.</cite> [<a href="https://doi.org/10.1038/onc.2015.326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4791217/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26364612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Targeting%20colorectal%20cancer%20via%20its%20microenvironment%20by%20inhibiting%20IGF-1%20receptor-insulin%20receptor%20substrate%20and%20STAT3%20signaling&amp;author=E%20Sanchez-Lopez&amp;author=E%20Flashner-Abramson&amp;author=S%20Shalapour&amp;author=Z%20Zhong&amp;author=K%20Taniguchi&amp;volume=35&amp;publication_year=2016&amp;pages=2634-2644&amp;pmid=26364612&amp;doi=10.1038/onc.2015.326&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b55-ijo-67-04-05787">
<span class="label">55.</span><cite>Ikushima H, Miyazono K. TGFbeta signalling: A complex web in cancer progression. Nat Rev Cancer. 2010;10:415–424. doi: 10.1038/nrc2853.</cite> [<a href="https://doi.org/10.1038/nrc2853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20495575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=TGFbeta%20signalling:%20A%20complex%20web%20in%20cancer%20progression&amp;author=H%20Ikushima&amp;author=K%20Miyazono&amp;volume=10&amp;publication_year=2010&amp;pages=415-424&amp;pmid=20495575&amp;doi=10.1038/nrc2853&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b56-ijo-67-04-05787">
<span class="label">56.</span><cite>Etscheid M, Beer N, Kress JA, Seitz R, Dodt J. Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma. Eur J Cell Biol. 2004;82:597–604. doi: 10.1078/0171-9335-00349.</cite> [<a href="https://doi.org/10.1078/0171-9335-00349" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15035435/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cell%20Biol&amp;title=Inhibition%20of%20bFGF/EGF-dependent%20endothelial%20cell%20proliferation%20by%20the%20hyaluronan-binding%20protease%20from%20human%20plasma&amp;author=M%20Etscheid&amp;author=N%20Beer&amp;author=JA%20Kress&amp;author=R%20Seitz&amp;author=J%20Dodt&amp;volume=82&amp;publication_year=2004&amp;pages=597-604&amp;pmid=15035435&amp;doi=10.1078/0171-9335-00349&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b57-ijo-67-04-05787">
<span class="label">57.</span><cite>Mueller MM, Fusenig NE. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004;4:839–849. doi: 10.1038/nrc1477.</cite> [<a href="https://doi.org/10.1038/nrc1477" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15516957/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Friends%20or%20foes-bipolar%20effects%20of%20the%20tumour%20stroma%20in%20cancer&amp;author=MM%20Mueller&amp;author=NE%20Fusenig&amp;volume=4&amp;publication_year=2004&amp;pages=839-849&amp;pmid=15516957&amp;doi=10.1038/nrc1477&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b58-ijo-67-04-05787">
<span class="label">58.</span><cite>Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, et al.  A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174–186. doi: 10.1038/s41568-019-0238-1.</cite> [<a href="https://doi.org/10.1038/s41568-019-0238-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7046529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31980749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=A%20framework%20for%20advancing%20our%20understanding%20of%20cancer-associated%20fibroblasts&amp;author=E%20Sahai&amp;author=I%20Astsaturov&amp;author=E%20Cukierman&amp;author=DG%20DeNardo&amp;author=M%20Egeblad&amp;volume=20&amp;publication_year=2020&amp;pages=174-186&amp;pmid=31980749&amp;doi=10.1038/s41568-019-0238-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b59-ijo-67-04-05787">
<span class="label">59.</span><cite>Shi Z, Yang W, Chen L, Yang DH, Zhou Q, Zhu J, Chen JJ, Huang RC, Chen ZS, Huang RP. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production. Breast Cancer Res Treat. 2012;135:737–747. doi: 10.1007/s10549-012-2196-0.</cite> [<a href="https://doi.org/10.1007/s10549-012-2196-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22923236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Enhanced%20chemosensitization%20in%20multidrug-resistant%20human%20breast%20cancer%20cells%20by%20inhibition%20of%20IL-6%20and%20IL-8%20production&amp;author=Z%20Shi&amp;author=W%20Yang&amp;author=L%20Chen&amp;author=DH%20Yang&amp;author=Q%20Zhou&amp;volume=135&amp;publication_year=2012&amp;pages=737-747&amp;pmid=22923236&amp;doi=10.1007/s10549-012-2196-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b60-ijo-67-04-05787">
<span class="label">60.</span><cite>Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 2015;367:103–107. doi: 10.1016/j.canlet.2015.07.009.</cite> [<a href="https://doi.org/10.1016/j.canlet.2015.07.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26188281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett&amp;title=The%20paradoxical%20role%20of%20IL-10%20in%20immunity%20and%20cancer&amp;author=MH%20Mannino&amp;author=Z%20Zhu&amp;author=H%20Xiao&amp;author=Q%20Bai&amp;author=MR%20Wakefield&amp;volume=367&amp;publication_year=2015&amp;pages=103-107&amp;pmid=26188281&amp;doi=10.1016/j.canlet.2015.07.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b61-ijo-67-04-05787">
<span class="label">61.</span><cite>Kasprzak A. The role of tumor microenvironment cells in colorectal cancer (CRC) cachexia. Int J Mol Sci. 2021;22:1565. doi: 10.3390/ijms22041565.</cite> [<a href="https://doi.org/10.3390/ijms22041565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7913937/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33557173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=The%20role%20of%20tumor%20microenvironment%20cells%20in%20colorectal%20cancer%20(CRC)%20cachexia&amp;author=A%20Kasprzak&amp;volume=22&amp;publication_year=2021&amp;pages=1565&amp;pmid=33557173&amp;doi=10.3390/ijms22041565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b62-ijo-67-04-05787">
<span class="label">62.</span><cite>Lan T, Chen L, Wei X. Inflammatory cytokines in cancer: Comprehensive understanding and clinical progress in gene therapy. Cells. 2021;10:100. doi: 10.3390/cells10010100.</cite> [<a href="https://doi.org/10.3390/cells10010100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7827947/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33429846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Inflammatory%20cytokines%20in%20cancer:%20Comprehensive%20understanding%20and%20clinical%20progress%20in%20gene%20therapy&amp;author=T%20Lan&amp;author=L%20Chen&amp;author=X%20Wei&amp;volume=10&amp;publication_year=2021&amp;pages=100&amp;pmid=33429846&amp;doi=10.3390/cells10010100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b63-ijo-67-04-05787">
<span class="label">63.</span><cite>Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, Tempst P. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem. 2004;76:1560–1570. doi: 10.1021/ac0352171.</cite> [<a href="https://doi.org/10.1021/ac0352171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15018552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anal%20Chem&amp;title=Serum%20peptide%20profiling%20by%20magnetic%20particle-assisted,%20automated%20sample%20processing%20and%20MALDI-TOF%20mass%20spectrometry&amp;author=J%20Villanueva&amp;author=J%20Philip&amp;author=D%20Entenberg&amp;author=CA%20Chaparro&amp;author=MK%20Tanwar&amp;volume=76&amp;publication_year=2004&amp;pages=1560-1570&amp;pmid=15018552&amp;doi=10.1021/ac0352171&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b64-ijo-67-04-05787">
<span class="label">64.</span><cite>Govorukhina NI, Keizer-Gunnink A, van der Zee AGJ, de Jong S, de Bruijn HWA, Bischoff R. Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion. J Chromatogr A. 2003;1009:171–178. doi: 10.1016/S0021-9673(03)00921-X.</cite> [<a href="https://doi.org/10.1016/S0021-9673(03)00921-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/13677657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chromatogr%20A&amp;title=Sample%20preparation%20of%20human%20serum%20for%20the%20analysis%20of%20tumor%20markers.%20Comparison%20of%20different%20approaches%20for%20albumin%20and%20gamma-globulin%20depletion&amp;author=NI%20Govorukhina&amp;author=A%20Keizer-Gunnink&amp;author=AGJ%20van%20der%20Zee&amp;author=S%20de%20Jong&amp;author=HWA%20de%20Bruijn&amp;volume=1009&amp;publication_year=2003&amp;pages=171-178&amp;pmid=13677657&amp;doi=10.1016/S0021-9673(03)00921-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b65-ijo-67-04-05787">
<span class="label">65.</span><cite>Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics. 2003;2:1096–1103. doi: 10.1074/mcp.M300031-MCP200.</cite> [<a href="https://doi.org/10.1074/mcp.M300031-MCP200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12917320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Proteomics&amp;title=Characterization%20of%20the%20low%20molecular%20weight%20human%20serum%20proteome&amp;author=RS%20Tirumalai&amp;author=KC%20Chan&amp;author=DA%20Prieto&amp;author=HJ%20Issaq&amp;author=TP%20Conrads&amp;volume=2&amp;publication_year=2003&amp;pages=1096-1103&amp;pmid=12917320&amp;doi=10.1074/mcp.M300031-MCP200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b66-ijo-67-04-05787">
<span class="label">66.</span><cite>Beutgen VM, Shinkevich V, Porschke J, Meena C, Steitz AM, von Strandmann P, Graumann J, Gómez-Serrano M. Secretome analysis using affinity proteomics and immunoassays: A focus on tumor biology. Mol Cell Proteomics. 2024;23:100830. doi: 10.1016/j.mcpro.2024.100830.</cite> [<a href="https://doi.org/10.1016/j.mcpro.2024.100830" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11417252/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39147028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Proteomics&amp;title=Secretome%20analysis%20using%20affinity%20proteomics%20and%20immunoassays:%20A%20focus%20on%20tumor%20biology&amp;author=VM%20Beutgen&amp;author=V%20Shinkevich&amp;author=J%20Porschke&amp;author=C%20Meena&amp;author=AM%20Steitz&amp;volume=23&amp;publication_year=2024&amp;pages=100830&amp;pmid=39147028&amp;doi=10.1016/j.mcpro.2024.100830&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b67-ijo-67-04-05787">
<span class="label">67.</span><cite>Ding Z, Wang N, Ji N, Chen Z. Proteomics technologies for cancer liquid biopsies. Mol Cancer. 2022;21:53. doi: 10.1186/s12943-022-01526-8.</cite> [<a href="https://doi.org/10.1186/s12943-022-01526-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8845389/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35168611/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer&amp;title=Proteomics%20technologies%20for%20cancer%20liquid%20biopsies&amp;author=Z%20Ding&amp;author=N%20Wang&amp;author=N%20Ji&amp;author=Z%20Chen&amp;volume=21&amp;publication_year=2022&amp;pages=53&amp;pmid=35168611&amp;doi=10.1186/s12943-022-01526-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b68-ijo-67-04-05787">
<span class="label">68.</span><cite>Sutandy FXR, Qian J, Chen C, Zhu H. Overview of protein microarrays. Curr Protoc Protein Sci Chapter. 2013;27:21–27. doi: 10.1002/0471140864.ps2701s72.</cite> [<a href="https://doi.org/10.1002/0471140864.ps2701s72" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3680110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23546620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Protoc%20Protein%20Sci%20Chapter&amp;title=Overview%20of%20protein%20microarrays&amp;author=FXR%20Sutandy&amp;author=J%20Qian&amp;author=C%20Chen&amp;author=H%20Zhu&amp;volume=27&amp;publication_year=2013&amp;pages=21-27&amp;pmid=23546620&amp;doi=10.1002/0471140864.ps2701s72&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b69-ijo-67-04-05787">
<span class="label">69.</span><cite>Sanchez-Carbayo M. Antibody arrays: Technical considerations and clinical applications in cancer. Clin Chem. 2006;52:1651–1659. doi: 10.1373/clinchem.2005.059592.</cite> [<a href="https://doi.org/10.1373/clinchem.2005.059592" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16809399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=Antibody%20arrays:%20Technical%20considerations%20and%20clinical%20applications%20in%20cancer&amp;author=M%20Sanchez-Carbayo&amp;volume=52&amp;publication_year=2006&amp;pages=1651-1659&amp;pmid=16809399&amp;doi=10.1373/clinchem.2005.059592&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b70-ijo-67-04-05787">
<span class="label">70.</span><cite>Huang R, Jiang W, Yang J, Mao YQ, Zhang Y, Yang W, Yang D, Burkholder B, Huang RF, Huang RP. A biotin label-based antibody array for high-content profiling of protein expression. Cancer Genom Proteom. 2010;7:129–141.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/20551245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genom%20Proteom&amp;title=A%20biotin%20label-based%20antibody%20array%20for%20high-content%20profiling%20of%20protein%20expression&amp;author=R%20Huang&amp;author=W%20Jiang&amp;author=J%20Yang&amp;author=YQ%20Mao&amp;author=Y%20Zhang&amp;volume=7&amp;publication_year=2010&amp;pages=129-141&amp;pmid=20551245&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b71-ijo-67-04-05787">
<span class="label">71.</span><cite>Wei W, Zhou H, Chen P, Huang XL, Huang L, Liang LJ, Guo CH, Zhou CF, Yu L, Fan LS, Wang W. Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells. J Exp Clin Canc Res. 2023;42:160. doi: 10.1186/s13046-023-02714-0.</cite> [<a href="https://doi.org/10.1186/s13046-023-02714-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10324144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37415190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Exp%20Clin%20Canc%20Res&amp;title=Cancer-associated%20fibroblast-derived%20PAI-1%20promotes%20lymphatic%20metastasis%20via%20the%20induction%20of%20EndoMT%20in%20lymphatic%20endothelial%20cells&amp;author=W%20Wei&amp;author=H%20Zhou&amp;author=P%20Chen&amp;author=XL%20Huang&amp;author=L%20Huang&amp;volume=42&amp;publication_year=2023&amp;pages=160&amp;pmid=37415190&amp;doi=10.1186/s13046-023-02714-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b72-ijo-67-04-05787">
<span class="label">72.</span><cite>Wei WF, Chen XJ, Liang LJ, Yu L, Wu XG, Zhou CF, Wang ZC, Fan LS, Hu Z, Liang L, Wang W. Periostin+ cancer-associated fibroblasts promote lymph node metastasis by impairing the lymphatic endothelial barriers in cervical squamous cell carcinoma. Mol Oncol. 2021;15:210–227. doi: 10.1002/1878-0261.12837.</cite> [<a href="https://doi.org/10.1002/1878-0261.12837" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7782076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33124726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Oncol&amp;title=Periostin+%20cancer-associated%20fibroblasts%20promote%20lymph%20node%20metastasis%20by%20impairing%20the%20lymphatic%20endothelial%20barriers%20in%20cervical%20squamous%20cell%20carcinoma&amp;author=WF%20Wei&amp;author=XJ%20Chen&amp;author=LJ%20Liang&amp;author=L%20Yu&amp;author=XG%20Wu&amp;volume=15&amp;publication_year=2021&amp;pages=210-227&amp;pmid=33124726&amp;doi=10.1002/1878-0261.12837&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b73-ijo-67-04-05787">
<span class="label">73.</span><cite>Sun C, Li X, Guo E, Li N, Zhou B, Lu H, Huang J, Xia M, Shan W, Wang B, et al.  MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis. Oncogene. 2020;39:1681–1695. doi: 10.1038/s41388-019-1090-1.</cite> [<a href="https://doi.org/10.1038/s41388-019-1090-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8290627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31705064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=MCP-1/CCR-2%20axis%20in%20adipocytes%20and%20cancer%20cell%20respectively%20facilitates%20ovarian%20cancer%20peritoneal%20metastasis&amp;author=C%20Sun&amp;author=X%20Li&amp;author=E%20Guo&amp;author=N%20Li&amp;author=B%20Zhou&amp;volume=39&amp;publication_year=2020&amp;pages=1681-1695&amp;pmid=31705064&amp;doi=10.1038/s41388-019-1090-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b74-ijo-67-04-05787">
<span class="label">74.</span><cite>Ryan D, Koziol J, ElShamy WM. Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis. Sci Rep. 2019;9:19150. doi: 10.1038/s41598-019-55702-w.</cite> [<a href="https://doi.org/10.1038/s41598-019-55702-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6915698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31844158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Targeting%20AXL%20and%20RAGE%20to%20prevent%20geminin%20overexpression-induced%20triple-negative%20breast%20cancer%20metastasis&amp;author=D%20Ryan&amp;author=J%20Koziol&amp;author=WM%20ElShamy&amp;volume=9&amp;publication_year=2019&amp;pages=19150&amp;pmid=31844158&amp;doi=10.1038/s41598-019-55702-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b75-ijo-67-04-05787">
<span class="label">75.</span><cite>Han K, Kim A, Kim D. Enhanced anti-cancer effects of conditioned medium from hypoxic human adult dermal fibroblasts on cervical cancer cells. Int J Mol Sci. 2022;23:5134. doi: 10.3390/ijms23095134.</cite> [<a href="https://doi.org/10.3390/ijms23095134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9100075/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35563525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Enhanced%20anti-cancer%20effects%20of%20conditioned%20medium%20from%20hypoxic%20human%20adult%20dermal%20fibroblasts%20on%20cervical%20cancer%20cells&amp;author=K%20Han&amp;author=A%20Kim&amp;author=D%20Kim&amp;volume=23&amp;publication_year=2022&amp;pages=5134&amp;pmid=35563525&amp;doi=10.3390/ijms23095134&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b76-ijo-67-04-05787">
<span class="label">76.</span><cite>Huang S, He L, Zhao Y, Wei Y, Wang Q, Gao Y, Jiang X. TREM1+ tumor-associated macrophages secrete CCL7 to promote hepatocellular carcinoma metastasis. J Cancer Res Clin. 2024;150:320. doi: 10.1007/s00432-024-05831-1.</cite> [<a href="https://doi.org/10.1007/s00432-024-05831-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11196310/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38914803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Res%20Clin&amp;title=TREM1+%20tumor-associated%20macrophages%20secrete%20CCL7%20to%20promote%20hepatocellular%20carcinoma%20metastasis&amp;author=S%20Huang&amp;author=L%20He&amp;author=Y%20Zhao&amp;author=Y%20Wei&amp;author=Q%20Wang&amp;volume=150&amp;publication_year=2024&amp;pages=320&amp;pmid=38914803&amp;doi=10.1007/s00432-024-05831-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b77-ijo-67-04-05787">
<span class="label">77.</span><cite>Zheng Y, Wang N, Wang S, Zhang J, Yang B, Wang Z. Chronic psychological stress promotes breast cancer pre-metastatic niche formation by mobilizing splenic MDSCs via TAM/CXCL1 signaling. J Exp Clin Canc Res. 2023;42:129. doi: 10.1186/s13046-023-02696-z.</cite> [<a href="https://doi.org/10.1186/s13046-023-02696-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10199643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37210553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Exp%20Clin%20Canc%20Res&amp;title=Chronic%20psychological%20stress%20promotes%20breast%20cancer%20pre-metastatic%20niche%20formation%20by%20mobilizing%20splenic%20MDSCs%20via%20TAM/CXCL1%20signaling&amp;author=Y%20Zheng&amp;author=N%20Wang&amp;author=S%20Wang&amp;author=J%20Zhang&amp;author=B%20Yang&amp;volume=42&amp;publication_year=2023&amp;pages=129&amp;pmid=37210553&amp;doi=10.1186/s13046-023-02696-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b78-ijo-67-04-05787">
<span class="label">78.</span><cite>Tatsuno R, Ichikawa J, Komohara Y, Pan C, Kawasaki T, Enomoto A, Aoki K, Hayakawa K, Iwata S, Jubashi T, Haro H. Pivotal role of IL-8 derived from the interaction between osteosarcoma and tumor-associated macrophages in osteosarcoma growth and metastasis via the FAK pathway. Cell Death Dis. 2024;15:108. doi: 10.1038/s41419-024-06487-y.</cite> [<a href="https://doi.org/10.1038/s41419-024-06487-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10834992/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38302407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Pivotal%20role%20of%20IL-8%20derived%20from%20the%20interaction%20between%20osteosarcoma%20and%20tumor-associated%20macrophages%20in%20osteosarcoma%20growth%20and%20metastasis%20via%20the%20FAK%20pathway&amp;author=R%20Tatsuno&amp;author=J%20Ichikawa&amp;author=Y%20Komohara&amp;author=C%20Pan&amp;author=T%20Kawasaki&amp;volume=15&amp;publication_year=2024&amp;pages=108&amp;pmid=38302407&amp;doi=10.1038/s41419-024-06487-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b79-ijo-67-04-05787">
<span class="label">79.</span><cite>Kim SY, Park S, Kim S, Ko J. CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer. Carcinogenesis. 2024;45:300–310. doi: 10.1093/carcin/bgad093.</cite> [<a href="https://doi.org/10.1093/carcin/bgad093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38085813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=CD133-containing%20microvesicles%20promote%20cancer%20progression%20by%20inducing%20M2-like%20tumor-associated%20macrophage%20polarization%20in%20the%20tumor%20microenvironment%20of%20colorectal%20cancer&amp;author=SY%20Kim&amp;author=S%20Park&amp;author=S%20Kim&amp;author=J%20Ko&amp;volume=45&amp;publication_year=2024&amp;pages=300-310&amp;pmid=38085813&amp;doi=10.1093/carcin/bgad093&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b80-ijo-67-04-05787">
<span class="label">80.</span><cite>Licarete E, Rauca VF, Luput L, Patras L, Sesarman A, Banciu M. The prednisolone phosphate-induced suppression of the angiogenic function of tumor-associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro. Oncol Rep. 2019;42:2694–2705. doi: 10.3892/or.2019.7346.</cite> [<a href="https://doi.org/10.3892/or.2019.7346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31578578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Rep&amp;title=The%20prednisolone%20phosphate-induced%20suppression%20of%20the%20angiogenic%20function%20of%20tumor-associated%20macrophages%20enhances%20the%20antitumor%20effects%20of%20doxorubicin%20on%20B16.F10%20murine%20melanoma%20cells%20in%20vitro&amp;author=E%20Licarete&amp;author=VF%20Rauca&amp;author=L%20Luput&amp;author=L%20Patras&amp;author=A%20Sesarman&amp;volume=42&amp;publication_year=2019&amp;pages=2694-2705&amp;pmid=31578578&amp;doi=10.3892/or.2019.7346&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b81-ijo-67-04-05787">
<span class="label">81.</span><cite>Wang Y, Chen J, Yang L, Li J, Wu W, Huang M, Lin L, Su S. Tumor-contacted neutrophils promote metastasis by a CD90-TIMP-1 juxtacrine-paracrine loop. Clin Cancer Res. 2019;25:1957–1969. doi: 10.1158/1078-0432.CCR-18-2544.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-18-2544" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30482778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Tumor-contacted%20neutrophils%20promote%20metastasis%20by%20a%20CD90-TIMP-1%20juxtacrine-paracrine%20loop&amp;author=Y%20Wang&amp;author=J%20Chen&amp;author=L%20Yang&amp;author=J%20Li&amp;author=W%20Wu&amp;volume=25&amp;publication_year=2019&amp;pages=1957-1969&amp;pmid=30482778&amp;doi=10.1158/1078-0432.CCR-18-2544&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b82-ijo-67-04-05787">
<span class="label">82.</span><cite>Lee T, Chen T, Kuo Y, Lan H, Yang M, Chu P. Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma. Neoplasia. 2023;35:100855. doi: 10.1016/j.neo.2022.100855.</cite> [<a href="https://doi.org/10.1016/j.neo.2022.100855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9677212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36410227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia&amp;title=Tumor-associated%20tissue%20eosinophilia%20promotes%20angiogenesis%20and%20metastasis%20in%20head%20and%20neck%20squamous%20cell%20carcinoma&amp;author=T%20Lee&amp;author=T%20Chen&amp;author=Y%20Kuo&amp;author=H%20Lan&amp;author=M%20Yang&amp;volume=35&amp;publication_year=2023&amp;pages=100855&amp;pmid=36410227&amp;doi=10.1016/j.neo.2022.100855&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b83-ijo-67-04-05787">
<span class="label">83.</span><cite>Benzing C, Lam H, Tsang CM, Rimmer A, Arroyo-Berdugo Y, Calle Y, Wells CM. TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells. BMC Cancer. 2019;19:1214. doi: 10.1186/s12885-019-6429-z.</cite> [<a href="https://doi.org/10.1186/s12885-019-6429-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6911299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31836008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=TIMP-2%20secreted%20by%20monocyte-like%20cells%20is%20a%20potent%20suppressor%20of%20invadopodia%20formation%20in%20pancreatic%20cancer%20cells&amp;author=C%20Benzing&amp;author=H%20Lam&amp;author=CM%20Tsang&amp;author=A%20Rimmer&amp;author=Y%20Arroyo-Berdugo&amp;volume=19&amp;publication_year=2019&amp;pages=1214&amp;pmid=31836008&amp;doi=10.1186/s12885-019-6429-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b84-ijo-67-04-05787">
<span class="label">84.</span><cite>Li Y, Jiang M, Aye L, Luo L, Zhang Y, Xu F, Wei Y, Peng D, He X, Gu J, et al.  UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment. Nat Commun. 2024;15:1200. doi: 10.1038/s41467-024-45340-w.</cite> [<a href="https://doi.org/10.1038/s41467-024-45340-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10853547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38331898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=UPP1%20promotes%20lung%20adenocarcinoma%20progression%20through%20the%20induction%20of%20an%20immunosuppressive%20microenvironment&amp;author=Y%20Li&amp;author=M%20Jiang&amp;author=L%20Aye&amp;author=L%20Luo&amp;author=Y%20Zhang&amp;volume=15&amp;publication_year=2024&amp;pages=1200&amp;pmid=38331898&amp;doi=10.1038/s41467-024-45340-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b85-ijo-67-04-05787">
<span class="label">85.</span><cite>Zhu H, Liu Y, Liu D, Ma YD, Hu ZY, Wang XY, Gu CS, Zhong Y, Long T, Kan HP, Li ZG. Role of TGFβ3-Smads-Sp1 axis in DcR3-mediated immune escape of hepatocellular carcinoma. Oncogenesis. 2019;8:43. doi: 10.1038/s41389-019-0152-0.</cite> [<a href="https://doi.org/10.1038/s41389-019-0152-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6692328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31409774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogenesis&amp;title=Role%20of%20TGF%CE%B23-Smads-Sp1%20axis%20in%20DcR3-mediated%20immune%20escape%20of%20hepatocellular%20carcinoma&amp;author=H%20Zhu&amp;author=Y%20Liu&amp;author=D%20Liu&amp;author=YD%20Ma&amp;author=ZY%20Hu&amp;volume=8&amp;publication_year=2019&amp;pages=43&amp;pmid=31409774&amp;doi=10.1038/s41389-019-0152-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b86-ijo-67-04-05787">
<span class="label">86.</span><cite>Xie G, Cheng T, Lin J, Zhang L, Zheng J, Liu Y, Xie G, Wang B, Yuan Y. Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy. J Immunother Cancer. 2018;6:88. doi: 10.1186/s40425-018-0401-3.</cite> [<a href="https://doi.org/10.1186/s40425-018-0401-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6134794/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30208943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunother%20Cancer&amp;title=Local%20angiotensin%20II%20contributes%20to%20tumor%20resistance%20to%20checkpoint%20immunotherapy&amp;author=G%20Xie&amp;author=T%20Cheng&amp;author=J%20Lin&amp;author=L%20Zhang&amp;author=J%20Zheng&amp;volume=6&amp;publication_year=2018&amp;pages=88&amp;pmid=30208943&amp;doi=10.1186/s40425-018-0401-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b87-ijo-67-04-05787">
<span class="label">87.</span><cite>Jiang K, Zhang Q, Fan Y, Li J, Zhang J, Wang W, Fan J, Guo Y, Liu S, Hao D, et al.  MYC inhibition reprograms tumor immune microenvironment by recruiting T lymphocytes and activating the CD40/CD40L system in osteosarcoma. Cell Death Discov. 2022;8:117. doi: 10.1038/s41420-022-00923-8.</cite> [<a href="https://doi.org/10.1038/s41420-022-00923-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8924240/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35292660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Discov&amp;title=MYC%20inhibition%20reprograms%20tumor%20immune%20microenvironment%20by%20recruiting%20T%20lymphocytes%20and%20activating%20the%20CD40/CD40L%20system%20in%20osteosarcoma&amp;author=K%20Jiang&amp;author=Q%20Zhang&amp;author=Y%20Fan&amp;author=J%20Li&amp;author=J%20Zhang&amp;volume=8&amp;publication_year=2022&amp;pages=117&amp;pmid=35292660&amp;doi=10.1038/s41420-022-00923-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b88-ijo-67-04-05787">
<span class="label">88.</span><cite>Wang X, Wang F, Zhang Z, Yang X, Zhang R, Song J. STK3 suppresses ovarian cancer progression by activating NF-κB signaling to recruit CD8+ T-Cells. J Immunol Res. 2020;2020:1–17. doi: 10.1155/2020/2450569.</cite> [<a href="https://doi.org/10.1155/2020/2450569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7542485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33062724/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunol%20Res&amp;title=STK3%20suppresses%20ovarian%20cancer%20progression%20by%20activating%20NF-%CE%BAB%20signaling%20to%20recruit%20CD8+%20T-Cells&amp;author=X%20Wang&amp;author=F%20Wang&amp;author=Z%20Zhang&amp;author=X%20Yang&amp;author=R%20Zhang&amp;volume=2020&amp;publication_year=2020&amp;pages=1-17&amp;pmid=33062724&amp;doi=10.1155/2020/2450569&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b89-ijo-67-04-05787">
<span class="label">89.</span><cite>Zhang L, Cascio S, Mellors JW, Buckanovich RJ, Osmanbeyoglu HU. Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. Commun Biol. 2024;7 doi: 10.1038/s42003-023-05733-x. 2023.06.07.544095.</cite> [<a href="https://doi.org/10.1038/s42003-023-05733-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10770164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38182756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun%20Biol&amp;title=Single-cell%20analysis%20reveals%20the%20stromal%20dynamics%20and%20tumor-specific%20characteristics%20in%20the%20microenvironment%20of%20ovarian%20cancer&amp;author=L%20Zhang&amp;author=S%20Cascio&amp;author=JW%20Mellors&amp;author=RJ%20Buckanovich&amp;author=HU%20Osmanbeyoglu&amp;volume=7&amp;publication_year=2024&amp;pmid=38182756&amp;doi=10.1038/s42003-023-05733-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b90-ijo-67-04-05787">
<span class="label">90.</span><cite>Sheng N, Shindo K, Ohuchida K, Shinkawa T, Zhang B, Feng H, Yamamoto T, Moriyama T, Ikenaga N, Nakata K, et al.  TAK1 promotes an immunosuppressive tumor microenvironment through cancer-associated fibroblast phenotypic conversion in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2024;30:5138–5153. doi: 10.1158/1078-0432.CCR-24-1004.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-24-1004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11565170/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39264265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=TAK1%20promotes%20an%20immunosuppressive%20tumor%20microenvironment%20through%20cancer-associated%20fibroblast%20phenotypic%20conversion%20in%20pancreatic%20ductal%20adenocarcinoma&amp;author=N%20Sheng&amp;author=K%20Shindo&amp;author=K%20Ohuchida&amp;author=T%20Shinkawa&amp;author=B%20Zhang&amp;volume=30&amp;publication_year=2024&amp;pages=5138-5153&amp;pmid=39264265&amp;doi=10.1158/1078-0432.CCR-24-1004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b91-ijo-67-04-05787">
<span class="label">91.</span><cite>Nakamura K, Kiniwa Y, Okuyama R. CCL5 production by fibroblasts through a local renin-angiotensin system in malignant melanoma affects tumor immune responses. J Cancer Res Clin. 2021;147:1993–2001. doi: 10.1007/s00432-021-03612-8.</cite> [<a href="https://doi.org/10.1007/s00432-021-03612-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11801846/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33770254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Res%20Clin&amp;title=CCL5%20production%20by%20fibroblasts%20through%20a%20local%20renin-angiotensin%20system%20in%20malignant%20melanoma%20affects%20tumor%20immune%20responses&amp;author=K%20Nakamura&amp;author=Y%20Kiniwa&amp;author=R%20Okuyama&amp;volume=147&amp;publication_year=2021&amp;pages=1993-2001&amp;pmid=33770254&amp;doi=10.1007/s00432-021-03612-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b92-ijo-67-04-05787">
<span class="label">92.</span><cite>SenGupta S, Hein LE, Xu Y, Zhang J, Konwerski JR, Li Y, Johnson C, Cai D, Smith JL, Parent CA. Triple-negative breast cancer cells recruit neutrophils by secreting TGF-β and CXCR2 ligands. Front Immunol. 2021;12:659996. doi: 10.3389/fimmu.2021.659996.</cite> [<a href="https://doi.org/10.3389/fimmu.2021.659996" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8071875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33912188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Triple-negative%20breast%20cancer%20cells%20recruit%20neutrophils%20by%20secreting%20TGF-%CE%B2%20and%20CXCR2%20ligands&amp;author=S%20SenGupta&amp;author=LE%20Hein&amp;author=Y%20Xu&amp;author=J%20Zhang&amp;author=JR%20Konwerski&amp;volume=12&amp;publication_year=2021&amp;pages=659996&amp;pmid=33912188&amp;doi=10.3389/fimmu.2021.659996&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b93-ijo-67-04-05787">
<span class="label">93.</span><cite>Ogawa R, Yamamoto T, Hirai H, Hanada K, Kiyasu Y, Nishikawa G, Mizuno R, Inamoto S, Itatani Y, Sakai Y, Kawada K. Loss of SMAD4 promotes colorectal cancer progression by recruiting tumor-associated neutrophils via the CXCL1/8-CXCR2 axis. Clin Cancer Res. 2019;25:2887–2899. doi: 10.1158/1078-0432.CCR-18-3684.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-18-3684" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30705034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Loss%20of%20SMAD4%20promotes%20colorectal%20cancer%20progression%20by%20recruiting%20tumor-associated%20neutrophils%20via%20the%20CXCL1/8-CXCR2%20axis&amp;author=R%20Ogawa&amp;author=T%20Yamamoto&amp;author=H%20Hirai&amp;author=K%20Hanada&amp;author=Y%20Kiyasu&amp;volume=25&amp;publication_year=2019&amp;pages=2887-2899&amp;pmid=30705034&amp;doi=10.1158/1078-0432.CCR-18-3684&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b94-ijo-67-04-05787">
<span class="label">94.</span><cite>Germann M, Zangger N, Sauvain M, Sempoux C, Bowler AD, Wirapati P, Kandalaft LE, Delorenzi M, Tejpar S, Coukos G, Radtke F. Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ. Embo Mol Med. 2020;12:e10681. doi: 10.15252/emmm.201910681.</cite> [<a href="https://doi.org/10.15252/emmm.201910681" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6949488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31793740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Embo%20Mol%20Med&amp;title=Neutrophils%20suppress%20tumor-infiltrating%20T%20cells%20in%20colon%20cancer%20via%20matrix%20metalloproteinase-mediated%20activation%20of%20TGF%CE%B2&amp;author=M%20Germann&amp;author=N%20Zangger&amp;author=M%20Sauvain&amp;author=C%20Sempoux&amp;author=AD%20Bowler&amp;volume=12&amp;publication_year=2020&amp;pages=e10681&amp;pmid=31793740&amp;doi=10.15252/emmm.201910681&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b95-ijo-67-04-05787">
<span class="label">95.</span><cite>Chan Y, Tan H, Lu Y, Zhang C, Cheng CS, Wu J, Wang N, Feng Y. Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Acta Pharm Sin B. 2023;13:1554–1567. doi: 10.1016/j.apsb.2023.01.020.</cite> [<a href="https://doi.org/10.1016/j.apsb.2023.01.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10150138/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37139434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharm%20Sin%20B&amp;title=Pancreatic%20melatonin%20enhances%20anti-tumor%20immunity%20in%20pancreatic%20adenocarcinoma%20through%20regulating%20tumor-associated%20neutrophils%20infiltration%20and%20NETosis&amp;author=Y%20Chan&amp;author=H%20Tan&amp;author=Y%20Lu&amp;author=C%20Zhang&amp;author=CS%20Cheng&amp;volume=13&amp;publication_year=2023&amp;pages=1554-1567&amp;pmid=37139434&amp;doi=10.1016/j.apsb.2023.01.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b96-ijo-67-04-05787">
<span class="label">96.</span><cite>Su S, Chen J, Yao H, Liu J, Yu S, Lao L, Wang M, Luo M, Xing Y, Chen F, et al.  CD10+GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell. 2018;172:841–856. doi: 10.1016/j.cell.2018.01.009.</cite> [<a href="https://doi.org/10.1016/j.cell.2018.01.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29395328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=CD10+GPR77+%20cancer-associated%20fibroblasts%20promote%20cancer%20formation%20and%20chemoresistance%20by%20sustaining%20cancer%20stemness&amp;author=S%20Su&amp;author=J%20Chen&amp;author=H%20Yao&amp;author=J%20Liu&amp;author=S%20Yu&amp;volume=172&amp;publication_year=2018&amp;pages=841-856&amp;pmid=29395328&amp;doi=10.1016/j.cell.2018.01.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b97-ijo-67-04-05787">
<span class="label">97.</span><cite>Zeng W, Xiong L, Wu W, Li S, Liu J, Yang L, Lao L, Huang P, Zhang M, Chen H, et al.  CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype. Oncogene. 2023;42:224–237. doi: 10.1038/s41388-022-02540-2.</cite> [<a href="https://doi.org/10.1038/s41388-022-02540-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9836934/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36418470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=CCL18%20signaling%20from%20tumor-associated%20macrophages%20activates%20fibroblasts%20to%20adopt%20a%20chemoresistance-inducing%20phenotype&amp;author=W%20Zeng&amp;author=L%20Xiong&amp;author=W%20Wu&amp;author=S%20Li&amp;author=J%20Liu&amp;volume=42&amp;publication_year=2023&amp;pages=224-237&amp;pmid=36418470&amp;doi=10.1038/s41388-022-02540-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b98-ijo-67-04-05787">
<span class="label">98.</span><cite>Papaccio F, Kovacs D, Bellei B, Caputo S, Migliano E, Cota C, Picardo M. Profiling cancer-associated fibroblasts in melanoma. Int J Mol Sci. 2021;22:7255. doi: 10.3390/ijms22147255.</cite> [<a href="https://doi.org/10.3390/ijms22147255" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8306538/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34298873/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Profiling%20cancer-associated%20fibroblasts%20in%20melanoma&amp;author=F%20Papaccio&amp;author=D%20Kovacs&amp;author=B%20Bellei&amp;author=S%20Caputo&amp;author=E%20Migliano&amp;volume=22&amp;publication_year=2021&amp;pages=7255&amp;pmid=34298873&amp;doi=10.3390/ijms22147255&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b99-ijo-67-04-05787">
<span class="label">99.</span><cite>Zhou B, Sun C, Li N, Shan W, Lu H, Guo L, Guo E, Xia M, Weng D, Meng L, et al.  Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways. Int J Oncol. 2016;48:2087–2097. doi: 10.3892/ijo.2016.3442.</cite> [<a href="https://doi.org/10.3892/ijo.2016.3442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26983899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Oncol&amp;title=Cisplatin-induced%20CCL5%20secretion%20from%20CAFs%20promotes%20cisplatin-resistance%20in%20ovarian%20cancer%20via%20regulation%20of%20the%20STAT3%20and%20PI3K/Akt%20signaling%20pathways&amp;author=B%20Zhou&amp;author=C%20Sun&amp;author=N%20Li&amp;author=W%20Shan&amp;author=H%20Lu&amp;volume=48&amp;publication_year=2016&amp;pages=2087-2097&amp;pmid=26983899&amp;doi=10.3892/ijo.2016.3442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b100-ijo-67-04-05787">
<span class="label">100.</span><cite>Che Y, Wang J, Li Y, Lu Z, Huang J, Sun S, Mao S, Lei Y, Zang R, Sun N, He J. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance. Cell Death Dis. 2018;9:759. doi: 10.1038/s41419-018-0808-2.</cite> [<a href="https://doi.org/10.1038/s41419-018-0808-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6037765/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29988148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Cisplatin-activated%20PAI-1%20secretion%20in%20the%20cancer-associated%20fibroblasts%20with%20paracrine%20effects%20promoting%20esophageal%20squamous%20cell%20carcinoma%20progression%20and%20causing%20chemoresistance&amp;author=Y%20Che&amp;author=J%20Wang&amp;author=Y%20Li&amp;author=Z%20Lu&amp;author=J%20Huang&amp;volume=9&amp;publication_year=2018&amp;pages=759&amp;pmid=29988148&amp;doi=10.1038/s41419-018-0808-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b101-ijo-67-04-05787">
<span class="label">101.</span><cite>Chrisochoidou Y, Roy R, Farahmand P, Gonzalez G, Doig J, Krasny L, Rimmer EF, Willis AE, MacFarlane M, Huang PH. Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell Death Dis. 2023;14:725. doi: 10.1038/s41419-023-06240-x.</cite> [<a href="https://doi.org/10.1038/s41419-023-06240-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10632403/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37938546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=Crosstalk%20with%20lung%20fibroblasts%20shapes%20the%20growth%20and%20therapeutic%20response%20of%20mesothelioma%20cells&amp;author=Y%20Chrisochoidou&amp;author=R%20Roy&amp;author=P%20Farahmand&amp;author=G%20Gonzalez&amp;author=J%20Doig&amp;volume=14&amp;publication_year=2023&amp;pages=725&amp;pmid=37938546&amp;doi=10.1038/s41419-023-06240-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b102-ijo-67-04-05787">
<span class="label">102.</span><cite>Wang C, Wang Y, Hong T, Ye J, Chu C, Zuo L, Zhang J, Cui X. Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma. Cell Death Differ. 2021;28:932–951. doi: 10.1038/s41418-020-00626-6.</cite> [<a href="https://doi.org/10.1038/s41418-020-00626-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7937678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33009518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Differ&amp;title=Targeting%20a%20positive%20regulatory%20loop%20in%20the%20tumor-macrophage%20interaction%20impairs%20the%20progression%20of%20clear%20cell%20renal%20cell%20carcinoma&amp;author=C%20Wang&amp;author=Y%20Wang&amp;author=T%20Hong&amp;author=J%20Ye&amp;author=C%20Chu&amp;volume=28&amp;publication_year=2021&amp;pages=932-951&amp;pmid=33009518&amp;doi=10.1038/s41418-020-00626-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b103-ijo-67-04-05787">
<span class="label">103.</span><cite>Liu H, Liang Z, Zhou C, Zeng Z, Wang F, Hu T, He X, Wu X, Wu X, Lan P. Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer. Signal Transduct Target Ther. 2021;6:144. doi: 10.1038/s41392-021-00534-2.</cite> [<a href="https://doi.org/10.1038/s41392-021-00534-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8032794/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33833221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduct%20Target%20Ther&amp;title=Mutant%20KRAS%20triggers%20functional%20reprogramming%20of%20tumor-associated%20macrophages%20in%20colorectal%20cancer&amp;author=H%20Liu&amp;author=Z%20Liang&amp;author=C%20Zhou&amp;author=Z%20Zeng&amp;author=F%20Wang&amp;volume=6&amp;publication_year=2021&amp;pages=144&amp;pmid=33833221&amp;doi=10.1038/s41392-021-00534-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b104-ijo-67-04-05787">
<span class="label">104.</span><cite>Re OL, Mazza T, Giallongo S, Sanna P, Rappa F, Luong TV, Volti GL, Drovakova A, Roskams T, Van Haele M, et al.  Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+ CD25+ FoxP3+ regulatory T cells activation. Theranostics. 2020;10:910–924. doi: 10.7150/thno.35045.</cite> [<a href="https://doi.org/10.7150/thno.35045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6929991/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31903159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Loss%20of%20histone%20macroH2A1%20in%20hepatocellular%20carcinoma%20cells%20promotes%20paracrine-mediated%20chemoresistance%20and%20CD4+%20CD25+%20FoxP3+%20regulatory%20T%20cells%20activation&amp;author=OL%20Re&amp;author=T%20Mazza&amp;author=S%20Giallongo&amp;author=P%20Sanna&amp;author=F%20Rappa&amp;volume=10&amp;publication_year=2020&amp;pages=910-924&amp;pmid=31903159&amp;doi=10.7150/thno.35045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b105-ijo-67-04-05787">
<span class="label">105.</span><cite>Guo Z, Zhang H, Fu Y, Kuang J, Zhao B, Zhang L, Lin J, Lin S, Wu D, Xie G. Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6. Cell Death Discov. 2023;9:6. doi: 10.1038/s41420-023-01306-3.</cite> [<a href="https://doi.org/10.1038/s41420-023-01306-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9837084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36635302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Discov&amp;title=Cancer-associated%20fibroblasts%20induce%20growth%20and%20radioresistance%20of%20breast%20cancer%20cells%20through%20paracrine%20IL-6&amp;author=Z%20Guo&amp;author=H%20Zhang&amp;author=Y%20Fu&amp;author=J%20Kuang&amp;author=B%20Zhao&amp;volume=9&amp;publication_year=2023&amp;pages=6&amp;pmid=36635302&amp;doi=10.1038/s41420-023-01306-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b106-ijo-67-04-05787">
<span class="label">106.</span><cite>Chu T, Yang J, Huang T, Liu H. Crosstalk with cancer-associated fibroblasts increases the growth and radiation survival of cervical cancer cells. Radiat Res. 2014;181:540–547. doi: 10.1667/RR13583.1.</cite> [<a href="https://doi.org/10.1667/RR13583.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24785588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiat%20Res&amp;title=Crosstalk%20with%20cancer-associated%20fibroblasts%20increases%20the%20growth%20and%20radiation%20survival%20of%20cervical%20cancer%20cells&amp;author=T%20Chu&amp;author=J%20Yang&amp;author=T%20Huang&amp;author=H%20Liu&amp;volume=181&amp;publication_year=2014&amp;pages=540-547&amp;pmid=24785588&amp;doi=10.1667/RR13583.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b107-ijo-67-04-05787">
<span class="label">107.</span><cite>Cao Y, Yin Y, Wang X, Wu Z, Liu Y, Zhang F, Lin J, Huang Z, Zhou L. Sublethal irradiation promotes the metastatic potential of hepatocellular carcinoma cells. Cancer Sci. 2021;112:265–274. doi: 10.1111/cas.14724.</cite> [<a href="https://doi.org/10.1111/cas.14724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7780048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33155388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci&amp;title=Sublethal%20irradiation%20promotes%20the%20metastatic%20potential%20of%20hepatocellular%20carcinoma%20cells&amp;author=Y%20Cao&amp;author=Y%20Yin&amp;author=X%20Wang&amp;author=Z%20Wu&amp;author=Y%20Liu&amp;volume=112&amp;publication_year=2021&amp;pages=265-274&amp;pmid=33155388&amp;doi=10.1111/cas.14724&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b108-ijo-67-04-05787">
<span class="label">108.</span><cite>Arshad A, Deutsch E, Vozenin M. Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration. PLoS One. 2015;10:e115447. doi: 10.1371/journal.pone.0115447.</cite> [<a href="https://doi.org/10.1371/journal.pone.0115447" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4312053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25635683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Simultaneous%20irradiation%20of%20fibroblasts%20and%20carcinoma%20cells%20repress%20the%20secretion%20of%20soluble%20factors%20able%20to%20stimulate%20carcinoma%20cell%20migration&amp;author=A%20Arshad&amp;author=E%20Deutsch&amp;author=M%20Vozenin&amp;volume=10&amp;publication_year=2015&amp;pages=e115447&amp;pmid=25635683&amp;doi=10.1371/journal.pone.0115447&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12370358/bin/IJO-67-4-05787-Supplementary_Data.xlsx" data-ga-action="click_feat_suppl" class="usa-link">IJO-67-4-05787-Supplementary_Data.xlsx</a><sup> (11.5KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Not applicable.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from International Journal of Oncology are provided here courtesy of <strong>Spandidos Publications</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3892/ijo.2025.5787"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ijo-67-04-05787.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370358/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370358/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370358%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370358/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370358/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370358/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40849816/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370358/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40849816/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370358/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370358/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="UtFPkOdZK4DwerC6Lr6fQoICAXNZY6c7UShwLiQ04KgJSepZB6g0XoBylHmhBelm">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
